A

AInvest - Latest News

https://www.ainvest.com
https://rsshub.app/ainvest/news (RSS订阅地址)

Thai Airways, Honda Hit by Thailand Floods as Disruption Spreads

<p>Days of torrential rain overwhelmed Bangkok's drainage and put two very different companies in the same headline. Thai Airways <a href="https://www.bloomberg.com/news/articles/2026-09-29/thailand-floods-hit-thai-airways-honda-as-disruption-spreads">canceled 22 flights scheduled for September 29–30</a> and apologized over a baggage backlog and delay-ridden schedule, while <a data-code="HMC" data-position="stock.1" data-marketid="169" data-stockname="Honda Motor" data-type="stock" href="https://www.ainvest.com/news/thai-airways-honda-hit-thailand-floods-disruption-spreads-2609/#*f:HMC:sc*#">Honda</a> suspended motorcycle production at one of its Thai plants for two days. The cabinet approved <a href="https://www.bloomberg.com/news/articles/2026-09-29/thailand-floods-hit-thai-airways-honda-as-disruption-spreads">2 billion baht ($59.5 million) in relief aid</a> for flood victims. For an investor, the instinct is to read that coupling as a storm spreading across the economy - and to price both names for a broader shock. That instinct deserves a closer look, because the flooding is not distributing its damage evenly at all.</p><p>The pairing pulls at a specific worry that investors learned fifteen years ago. In 2011, Thailand's floods <a href="https://www.just-auto.com/features/october-2012-management-briefing-thailands-floods-and-their-impact-on-supply-chain-strategies/">shut Honda's car plant in Ayutthaya for six months</a> - the only major factory in the country to be completely flooded - and the parts shortage rippled into <a href="https://www.automotivelogistics.media/supply-chain-planning/thai-floods-affect-hondas-global-output/182083">production cuts across all six of Honda's North American plants, running them at roughly half their planned output</a>. That is the template the market files under "Thailand flooding": a localized weather event that becomes a global supply-chain shock. The 2026 version began looking different almost immediately, and the difference is where the investment judgment lives.</p><h2>The 2011 lesson, replayed and rejected</h2><p>The current flood hit the city, not the factories. The damage visible so far is concentrated in Bangkok and its operations: an overwhelmed drainage system, schools turned into evacuation centers, and airlines whose ground staff could not reach work. That is a service-economy event, not an industrial one.</p><backtest-component code="SPY" id="event_001" range="3" market="169"></backtest-component> <stock-card dataurl="https://cdn.ainvest.com/news/visual/visual_components/viz_2qzstn87.json"></stock-card> <img data-src="https://imgproxy.citrusreader.com/br6m8b7P8uSoYqm5TQxUw6IYDGIrcN4xiUC07KRcohc/raw:1/aHR0cHM6Ly9jZG4uYWludmVzdC5jb20vYWlnYy9oeGNtcC9pbWFnZXMvY29tcHJlc3MtcXdlbl9nZW5lcmF0ZWRfMTc5MDY1Nzc1MTQ5OC5qcGcucG5n" style="max-width:100%;" src="https://imgproxy.citrusreader.com/br6m8b7P8uSoYqm5TQxUw6IYDGIrcN4xiUC07KRcohc/raw:1/aHR0cHM6Ly9jZG4uYWludmVzdC5jb20vYWlnYy9oeGNtcC9pbWFnZXMvY29tcHJlc3MtcXdlbl9nZW5lcmF0ZWRfMTc5MDY1Nzc1MTQ5OC5qcGcucG5n" referrerpolicy="no-referrer"><p>Thai Airways is the clearest case. The airline's problem is operational and reputational, not a blow to its cash flows from lost demand. The baggage backlog alone was severe - <a href="https://www.thaiexaminer.com/thai-news-foreigners/2026/09/29/thai-airways-ceo-apologises-for-ongoing-flooding-crisis-issues-with-defective-carts-and-delayed-flights/">bags from 52 flights remained undelivered and 34 services were delayed</a> on September 28, with <a href="https://www.thaiexaminer.com/thai-news-foreigners/2026/09/29/thai-airways-ceo-apologises-for-ongoing-flooding-crisis-issues-with-defective-carts-and-delayed-flights/">rival ground-handling companies operating normally</a> through the same stretch. When competitors handle the same storm without difficulty, the disruption looks company-specific rather than structural: Thai Airways' own staff shortages and baggage equipment, not a flooded country, did most of the damage. The CEO apologized publicly, and the <a href="https://www.bloomberg.com/news/articles/2026-09-29/thailand-floods-hit-thai-airways-honda-as-disruption-spreads">tourism minister called for an urgent board meeting at the finance ministry, the airline's largest shareholder</a>. That is a governance and brand event for a government-controlled carrier, not evidence that its economics have changed.</p><visualization data="{&quot;components&quot;:[{&quot;show_type&quot;:&quot;jgyNewLowcode&quot;,&quot;data&quot;:{&quot;columns&quot;:[{&quot;type&quot;:&quot;Object&quot;,&quot;index_name&quot;:&quot;strategy_basic_info&quot;,&quot;key&quot;:&quot;strategy_basic_info&quot;},{&quot;type&quot;:&quot;Object&quot;,&quot;index_name&quot;:&quot;backtest_condition&quot;,&quot;key&quot;:&quot;backtest_condition&quot;},{&quot;type&quot;:&quot;STR&quot;,&quot;index_name&quot;:&quot;backtest_result&quot;,&quot;key&quot;:&quot;backtest_result&quot;}],&quot;datas&quot;:[{&quot;backtest_result&quot;:&quot;https://cdn.ainvest.com/backtest/agent/session/784562/visual-component/e6934de3-1d40-4fd5-b71f-d133e7991b86/spy_backtest_results.json&quot;,&quot;backtest_condition&quot;:{&quot;risk_control&quot;:{&quot;display_name&quot;:&quot;Risk Control&quot;,&quot;parameters&quot;:{&quot;take_profit&quot;:{&quot;unit&quot;:&quot;%&quot;,&quot;display_name&quot;:&quot;Take-Profit&quot;,&quot;value&quot;:8},&quot;stop_loss&quot;:{&quot;unit&quot;:&quot;%&quot;,&quot;display_name&quot;:&quot;Stop-Loss&quot;,&quot;value&quot;:4},&quot;max_holding_days&quot;:{&quot;display_name&quot;:&quot;Hold Days&quot;,&quot;value&quot;:20}}},&quot;open_signal&quot;:{&quot;criteria&quot;:&quot;RSI(14) crosses above 50&quot;,&quot;display_name&quot;:&quot;Open Signal&quot;,&quot;type&quot;:&quot;criteria&quot;},&quot;sell_signal&quot;:{&quot;criteria&quot;:&quot;RSI(14) crosses below 50, 20-day max hold, +8% TP, -4% SL&quot;,&quot;display_name&quot;:&quot;Close Signal&quot;,&quot;type&quot;:&quot;criteria&quot;},&quot;object&quot;:{&quot;ticker&quot;:[&quot;SPY&quot;],&quot;display_name&quot;:&quot;SPY&quot;,&quot;type&quot;:&quot;ticker&quot;}},&quot;strategy_basic_info&quot;:{&quot;name&quot;:&quot;RSI(14) Crossover Strategy&quot;,&quot;description&quot;:&quot;Long-only strategy on SPY entering when RSI(14) crosses above 50 and exiting on RSI(14) cross below 50, 20-day max hold, +8% TP, or -4% SL.&quot;}}]},&quot;config&quot;:{&quot;type&quot;:&quot;iwcapp/stockBackTestTool&quot;,&quot;version&quot;:&quot;0.0.3&quot;,&quot;url&quot;:&quot;//cdn.ainvest.com/frontResources/s/foiegras/stockBackTestTool/0.0.3/stockBackTestTool@0.0.3index.js&quot;},&quot;uuid&quot;:&quot;1789632552252_2c4af7b4&quot;}],&quot;page&quot;:{&quot;layout&quot;:{&quot;layout_data&quot;:&quot;[{\&quot;uuid\&quot;: \&quot;1789632552252_2c4af7b4\&quot;, \&quot;show_type\&quot;: \&quot;jgyNewLowcode\&quot;}]&quot;,&quot;layout_mode&quot;:&quot;grid&quot;}}}"></visualization><p>The financial surface of those disruptions is thin. Refunds, ticket credits, and a few canceled days of flying dent revenue temporarily, but an airline's flood exposure is not the same as a factory's. So the real question for Thai Airways is whether the reputational hit to Thailand's tourism image lasts - the minister's own concern - because tourism demand is what the airline ultimately sells.</p><h2>Why Honda is watched differently</h2><p>Honda is the name where the 2011 memory does the real work, and where investors should distinguish the headline from the mechanism. So far, the flood cost Honda <a href="https://www.bloomberg.com/news/articles/2026-09-29/thailand-floods-hit-thai-airways-honda-as-disruption-spreads">two days of motorcycle production at a single plant, with operations expected to resume on Wednesday</a>. The wider <a data-code="861023" data-position="stock.2" data-marketid="89" data-stockname="Automobiles (Industry)" data-type="stock" href="https://www.ainvest.com/news/thai-airways-honda-hit-thailand-floods-disruption-spreads-2609/#*f:861023:sc*#">auto industry</a> absorbed the disruption with minimal impact: the Federation of Thai Industries <a href="https://www.bloomberg.com/news/articles/2026-09-29/thailand-floods-hit-thai-airways-honda-as-disruption-spreads">kept its 2026 production target of 1.45 million vehicles unchanged</a>, and most factories kept running with parts shipments largely unaffected.</p><p>Two days at one location is immaterial to a global automaker of Honda's scale. The reason it is worth watching at all is that Honda's Thai footprint has shifted since 2011. The company consolidated its auto assembly at a newer plant in Prachin Buri and <a href="https://www.just-auto.com/news/honda-to-end-production-at-thai-plant/">shut its Ayutthaya factory outright in 2025</a>, precisely to concentrate output and raise utilization. That consolidation is the source of both the vulnerability and the exposure: the Eastern Seaboard corridor - Prachin Buri and, further down, Rayong, where much of Thailand's <a data-code="861023" data-position="stock.3" data-marketid="89" data-stockname="Automobiles (Industry)" data-type="stock" href="https://www.ainvest.com/news/thai-airways-honda-hit-thailand-floods-disruption-spreads-2609/#*f:861023:sc*#">automotive</a> supply base sits - is where another round of floodwater would actually damage Honda and its parts suppliers.</p><h2>The condition that would change the answer</h2><p>The government is treating prevention seriously: the cabinet considered a <a href="https://www.bloomberg.com/news/articles/2026-09-29/thailand-floods-hit-thai-airways-honda-as-disruption-spreads">160 billion-baht ($4.8 billion), eight-year project to divert floodwater</a> from the north, with some funding allocated and borrowing potentially used to accelerate construction. That is a telling indicator of where officials expect the risk to land - not in the streets of Bangkok, but in the watershed that feeds the industrial belt.</p><p>Nothing in the record so far lets you conclude this is 2011 again for Honda, or a structural blow to Thai Airways. The measured, temporary facts - a two-day plant halt, flight cancellations measured in days, an unchanged industry production target - argue for contained disruption. The judgment would change if the water moved inland: <a href="https://www.bloomberg.com/news/articles/2026-09-29/thailand-floods-hit-thai-airways-honda-as-disruption-spreads">authorities are already watching Prachin Buri and Rayong</a>, and Rayong faces heavy rain and further releases from spillways. That corridor is the evidence to monitor. If it floods the way Ayutthaya did in 2011, the "contained disruption" reading fails, and the headline's coupling of an airline and an automaker would begin to earn its alarm - because then Honda's parts base, not its two lost days, would be at risk.</p> <fundamentals-card dataurl="https://cdn.ainvest.com/news/visual/visual_components/viz_2qzstn87.json"></fundamentals-card>

2026/9/29
阅读更多

The Iran "rejection" isn't a new shock - it's a seven-month grind rolling into your gas pump

<p>Trump's rejection of Iran's seven-day truce shoved Brent crude <a href="https://finance.yahoo.com/energy/articles/oil-rebounds-trump-rejects-iran-221457073.html">up $2.28, or 2.2%, to $106.60</a> a barrel on Monday, with <a data-code="WTI" data-position="stock.1" data-marketid="169" data-stockname="W&amp;T Offshore" data-type="stock" href="https://www.ainvest.com/news/iran-rejection-isn-shock-month-grind-rolling-gas-pump-2609/#*f:WTI:sc*#">WTI</a> climbing to <a href="https://finance.yahoo.com/energy/articles/oil-rebounds-trump-rejects-iran-221457073.html">$94.11</a>. Read the headline literally and it looks like the first day of a fresh war. It is not. <a href="https://finance.yahoo.com/energy/articles/oil-rebounds-trump-rejects-iran-221457073.html">The fighting began in February</a>, the Strait of Hormuz has been partially shut ever since, and each peace chance since August - talks reported, then a truce offered, then rejected - has reset the price clock without resetting the supply bind underneath it. So the trade isn't whether today's answer is yes or no. It is how far a seven-month-old impairment has already reached into the one energy number you actually see every week: the price of gasoline.</p><h2>A grind with a partial closure, not a shut strait</h2><p>The first thing to correct is the calendar. This is not an overnight escalation; it is a slow-motion supply loss that has been compounding since the U.S. and Israel attacked Iran in February. Because the crisis arrived in stages, the market keeps pricing "ceasefire chance" and then "no deal" in a loop - the September 28 jump is just the latest bend in that loop, and crude still <a href="https://finance.yahoo.com/energy/articles/oil-prices-spike-trump-rejects-034903535.html">finished well below its session highs</a> because Trump said talks would resume in the coming days.</p><p>What has not reset is the production bind. Roughly <a href="https://finance.yahoo.com/energy/articles/oil-rebounds-trump-rejects-iran-221457073.html">20 million barrels a day, about one-fifth of the world's supply</a>, used to move through the Strait of Hormuz. In September that flow ran to about <a href="https://finance.yahoo.com/energy/articles/oil-rebounds-trump-rejects-iran-221457073.html">7.4 million barrels a day</a>. That is the crux of the whole story: the Strait is degraded, not closed, which is exactly the kind of partial, persistent impairment that erodes supply quietly for months rather than announcing itself in one spike.</p><backtest-component code="XLE" id="strategy_010" range="3" market="169"></backtest-component><h2>The firewall that's holding - at a rising cost</h2><p>Here is the argument for the glass being half full, and it matters because it is the main reason Brent isn't already at $150. The loss isn't total because the closure is partial and because big producers have re-routed around it. Middle East crude exports <a href="https://finance.yahoo.com/energy/articles/oil-rebounds-trump-rejects-iran-221457073.html">rebounded to 12.8 million barrels a day in September</a>, the highest of the war, pulled up by Saudi Arabia and the UAE.</p><p>But every re-route costs money, and that cost is the amplifier the market rates too lightly. Saudi Arabia has had to divert cargoes from the Red Sea port of Yanbu to Ras Tanura after <a href="https://finance.yahoo.com/energy/articles/oil-rebounds-trump-rejects-iran-221457073.html">attacks damaged its East-West pipeline</a>, pushing freight to record levels and forcing Aramco to weigh discounts on its Oman-loaded cargoes just to keep buyers. On the other end, U.S. refineries are running <a href="https://www.reuters.com/business/energy/americans-hit-with-record-high-labor-day-weekend-gasoline-prices-2026-09-05/">near 98% of capacity</a>, their most since 2018, after <a href="https://www.cleveland.com/news/2026/09/sticker-shock-gas-prices-soaring-for-sept-17-diesel-outages-reported-in-3-states.html">diesel outages were reported in three states</a>, and Iran-backed Houthis have <a href="https://finance.yahoo.com/energy/articles/oil-prices-spike-trump-rejects-034903535.html">seized Yemen's entire Red Sea coast</a>, closing Bab al-Mandab on the opposite side of the Arabian peninsula. The pipeline is narrower, the backup route is more expensive, and both exits are pinched at once.</p><visualization data="{&quot;components&quot;:[{&quot;show_type&quot;:&quot;jgyNewLowcode&quot;,&quot;data&quot;:{&quot;columns&quot;:[{&quot;type&quot;:&quot;Object&quot;,&quot;index_name&quot;:&quot;strategy_basic_info&quot;,&quot;key&quot;:&quot;strategy_basic_info&quot;},{&quot;type&quot;:&quot;Object&quot;,&quot;index_name&quot;:&quot;backtest_condition&quot;,&quot;key&quot;:&quot;backtest_condition&quot;},{&quot;type&quot;:&quot;STR&quot;,&quot;index_name&quot;:&quot;backtest_result&quot;,&quot;key&quot;:&quot;backtest_result&quot;}],&quot;datas&quot;:[{&quot;backtest_result&quot;:&quot;https://cdn.ainvest.com/backtest/agent/session/784562/visual-component/22684ddd-6976-4e07-a6dd-61189bf7b7dc/xle_backtest_results.json&quot;,&quot;backtest_condition&quot;:{&quot;risk_control&quot;:{&quot;display_name&quot;:&quot;Risk Control&quot;,&quot;parameters&quot;:{&quot;take_profit&quot;:{&quot;unit&quot;:&quot;%&quot;,&quot;display_name&quot;:&quot;Take-Profit&quot;,&quot;value&quot;:8.0},&quot;stop_loss&quot;:{&quot;unit&quot;:&quot;%&quot;,&quot;display_name&quot;:&quot;Stop-Loss&quot;,&quot;value&quot;:4.0},&quot;max_holding_days&quot;:{&quot;display_name&quot;:&quot;Hold Days&quot;,&quot;value&quot;:20}}},&quot;open_signal&quot;:{&quot;criteria&quot;:&quot;Close price > 50-day Simple Moving Average&quot;,&quot;display_name&quot;:&quot;Open Signal&quot;,&quot;type&quot;:&quot;criteria&quot;},&quot;sell_signal&quot;:{&quot;criteria&quot;:&quot;Close price < 200-day SMA OR holding period > 20 days OR Take-Profit (+8%) OR Stop-Loss (-4%)&quot;,&quot;display_name&quot;:&quot;Close Signal&quot;,&quot;type&quot;:&quot;criteria&quot;},&quot;object&quot;:{&quot;ticker&quot;:[&quot;XLE&quot;],&quot;display_name&quot;:&quot;XLE&quot;,&quot;type&quot;:&quot;ticker&quot;}},&quot;strategy_basic_info&quot;:{&quot;name&quot;:&quot;XLE Long-Only Strategy (50/200 SMA with TP/SL)&quot;,&quot;description&quot;:&quot;A long-only strategy for XLE that enters when the close price is above the 50-day SMA and exits when the close price is below the 200-day SMA, after 20 trading days, or upon hitting take-profit (+8%) or stop-loss (-4%) levels. The strategy was backtested over the past 2 years (Oct 2022 - Oct 2024) and resulted in a total return of -23.94% with a maximum drawdown of 26.54%.&quot;}}]},&quot;config&quot;:{&quot;type&quot;:&quot;iwcapp/stockBackTestTool&quot;,&quot;version&quot;:&quot;0.0.3&quot;,&quot;url&quot;:&quot;//cdn.ainvest.com/frontResources/s/foiegras/stockBackTestTool/0.0.3/stockBackTestTool@0.0.3index.js&quot;},&quot;uuid&quot;:&quot;1789635328639_a63ab938&quot;}],&quot;page&quot;:{&quot;layout&quot;:{&quot;layout_data&quot;:&quot;[{\&quot;uuid\&quot;: \&quot;1789635328639_a63ab938\&quot;, \&quot;show_type\&quot;: \&quot;jgyNewLowcode\&quot;}]&quot;,&quot;layout_mode&quot;:&quot;grid&quot;}}}"></visualization><p>So the firewall is real but it is a paid firewall. Each re-router barrel works only while it is economical, and record freight rates are the visible tax on keeping the chain alive.</p><h2>Where the shock actually lands: your gas pump and the Fed</h2><p>Now the move that a beginner most often gets backwards. Oil going up is not, for most portfolios, an argument to load up on energy stocks or to dump your index fund. Energy is a modest slice of the S&amp;P 500, far too small for an oil spike to move the broad market through its own weight. Yet the <a href="https://finance.yahoo.com/energy/articles/oil-prices-spike-trump-rejects-034903535.html">S&amp;P 500 fell 0.8% the same day crude jumped</a>. The connection is not crude hitting the index; it is the shared driver underneath both moves: inflation and what it does to interest rates.</p><p>That shared driver is the real exposed node, and it reaches you through the pump. The average U.S. gallon of unleaded ran about <a href="https://www.cleveland.com/news/2026/09/sticker-shock-gas-prices-soaring-for-sept-17-diesel-outages-reported-in-3-states.html">$4.43 in mid-September</a>, the highest ever recorded this late in the calendar year and already past the <a href="https://www.reuters.com/business/energy/americans-hit-with-record-high-labor-day-weekend-gasoline-prices-2026-09-05/">$3.83 record set back in 2012</a>. Before the war, the market's path of least resistance was a cooling inflation and a Fed that could start cutting; every month that crude holds near triple digits is a month that keeps gasoline, and with it the inflation reading, elevated, and pushes those rate cuts further away. That is precisely why the day's real anxiety, as one <a data-code="IBKR" data-position="stock.2" data-marketid="185" data-stockname="Interactive Brokers Group" data-type="stock" href="https://www.ainvest.com/news/iran-rejection-isn-shock-month-grind-rolling-gas-pump-2609/#*f:IBKR:sc*#">Interactive Brokers</a> strategist put it, was that Wall Street worried the Fed would have to <a href="https://finance.yahoo.com/energy/articles/oil-prices-spike-trump-rejects-034903535.html">meaningfully tighten to constrain inflation</a>.</p><p>Call it a common shock rather than contagion: oil and equities are not infecting each other, they are both repricing the same inflation-and-rates factor. But a common shock still lands on the same household - the higher the pump price, the shakier the case for rate cuts, and the more the entire equity multiple has to stay compressed.</p> <img data-src="https://imgproxy.citrusreader.com/3zdcFgzNnaN6jLRA0r5wsLPupp9vquGlXp3ccqh57Vg/raw:1/aHR0cHM6Ly9jZG4uYWludmVzdC5jb20vYWlnYy9oeGNtcC9pbWFnZXMvY29tcHJlc3MtcXdlbl9nZW5lcmF0ZWRfMTc5MDY1NzcyOTg2NC5qcGcucG5n" style="max-width:100%;" src="https://imgproxy.citrusreader.com/3zdcFgzNnaN6jLRA0r5wsLPupp9vquGlXp3ccqh57Vg/raw:1/aHR0cHM6Ly9jZG4uYWludmVzdC5jb20vYWlnYy9oeGNtcC9pbWFnZXMvY29tcHJlc3MtcXdlbl9nZW5lcmF0ZWRfMTc5MDY1NzcyOTg2NC5qcGcucG5n" referrerpolicy="no-referrer"> <h2>The backstop that used to end these worst cases is thinner now</h2><p>The amplifier deserves one more layer, because the firewall that historically ended oil shocks has been spent down. The Strategic Petroleum Reserve holds <a href="https://realeconomy.rsmus.com/market-minute-u-s-strategic-petroleum-reserve-continues-to-drop/">roughly 285 million barrels</a>, only about 33 million above the 252.4 million congressionally mandated minimum, and much of what was released was turned into loans that aren't due to be repaid <a href="https://realeconomy.rsmus.com/market-minute-u-s-strategic-petroleum-reserve-continues-to-drop/">until September 2028</a>. In 2022 the reserve was the cushion that let Washington absorb a supply shock; the headroom now is measured in tens of millions of barrels rather than hundreds. It is not empty, but it is no longer the shock absorber it used to be.</p><p>That is the honest shape of the situation: a partial closure the market keeps re-pricing as diplomacy comes and goes, a re-route firewall that holds only at record freight cost, and a bare policy cushion. None of it proves a collapse is coming. It all argues the bind is old, real, and priced to persist until something actually changes the barrels.</p><h2>The tripwire runs both ways</h2><p>Here is how you tell which bend in the loop you are in. The peace side: if a ceasefire actually takes and Brent gives back the jump, slipping from $106 back toward the low nineties, then the rejection was one more repricing, the re-route firewall did its job, and retail gasoline should follow crude lower within weeks - no portfolio action warranted. The tightening side: if Brent holds above the roughly $104 it sat at before the rejection and keeps grinding higher, and the $4-plus gallon stays pinned near a late-season record into October, then the impairment is real and the inflation-and-Fed channel is the live risk for broad holdings.</p><p>The war you're reading about today isn't new. The number that tells you whether it still matters is what a gallon costs, and whether Brent keeps climbing - not which word came out of the negotiations this time. That is the variable that was never mispriced, because it is the one that reaches the household directly.</p>

2026/9/29
阅读更多

Corteva's loyalty program was a patent that refused to expire

<p>Here is a loyalty program whose entire job was to make people disloyal to the market. <a data-code="CTVA" data-position="stock.1" data-marketid="169" data-stockname="Corteva" data-type="stock" href="https://www.ainvest.com/news/corteva-loyalty-program-patent-refused-expire-2609/#*f:CTVA:sc*#">Corteva</a>, the crop-science company, ran a discount program that paid its distributors to keep their purchases of cheaper generic pesticides below a <a href="https://iowacapitaldispatch.com/2026/09/28/states-ftc-secure-settlement-in-suit-against-corteva-pesticide-loyalty-programs/">"very low threshold."</a> The more a distributor stuck with Corteva's own chemistry, the more it got paid - and the less room that left on the shelf for the generic rivals that would otherwise undercut the price.</p><p>That is weird. The whole purpose of a loyalty discount is to keep your customers buying from you, and that is exactly what this one did. The strange part is what the program was quietly doing for Corteva's shareholders. A pesticide patent lasts twenty years, and when it expires, the chemistry goes generic and price collapses toward a commodity. The loyalty program was a way to keep that from happening - to hold the expired patent's pricing power together with a distributor contract instead of with the law.</p><h2>A patent cliff, defended by contract</h2><p>This is the standard agricultural-chemistry story, the "patent cliff": Corteva's crop-protection segment does about <a href="https://investors.corteva.com/static-files/03f67bb9-c5b1-4679-8bf0-984bb4fdfeb2">$7.5 billion of net sales a year</a>, and a meaningful slice sits in mature chemistry whose intellectual-property protection has lapsed. In a normal market, that mature portfolio would get cheaper every year as generics flood in.</p><backtest-component code="CTVA" id="strategy_006" range="3" market="169"></backtest-component> <stock-card dataurl="https://cdn.ainvest.com/news/visual/visual_components/viz_o3zbgq8i.json"></stock-card><p>The Federal Trade Commission and twelve states alleged that Corteva bent that normal process. The enforcement action centered on three post-patent active ingredients - <a href="https://www.agbull.com/cortevas-35-million-ftc-deal-opens-door-to-more-generic-pesticides/">acetochlor and rimsulfuron, both herbicides, and oxamyl</a>, an insecticide and nematicide. The theory, spelled out loosely by the settling states, was that a generic maker offering a cheaper product could not win distribution, because a distributor who switched would risk forfeiting the payments it earned on everything else it bought from Corteva. That is how a small program defends a big position: the rebate on the still-branded volume is the toll booth that keeps the generic out of the store.</p><p>The allegation is not that Corteva broke the patent clock. It is that Corteva kept collecting after the clock ran out, replacing the expired legal monopoly with a financial one.</p><h2>The $35 million was the cheap part</h2><p>The settlement is a check plus a set of rules. Corteva <a href="https://www.dtnpf.com/agriculture/web/ag/news/crops/article/2026/09/28/corteva-pay-35m-12-states-end-crop-2">will pay $35 million to the twelve states, dismantle the loyalty program</a>, and accept <a href="https://iowacapitaldispatch.com/2026/09/28/states-ftc-secure-settlement-in-suit-against-corteva-pesticide-loyalty-programs/">ten years of restrictions</a>. The operative limit is a clean number: Corteva may not condition distributor benefits on a distributor <a href="https://www.agbull.com/cortevas-35-million-ftc-deal-opens-door-to-more-generic-pesticides/">buying more than 50% of its requirements</a> for a covered post-patent ingredient. Notably the rule polices the incentive, not the purchase - a distributor may still voluntarily buy all of its supply from Corteva; Corteva just cannot pay it to.</p> <fundamentals-card dataurl="https://cdn.ainvest.com/news/visual/visual_components/viz_o3zbgq8i.json"></fundamentals-card> <p>For the investor, fix the scale before judging. $35 million against a roughly $7.5 billion annual crop-protection business, or a market cap around $52 billion, is a rounding error - the stock fell about 1% on the news, and Corteva had already reserved for the cost in its second-quarter filings. <a href="https://www.agbull.com/cortevas-35-million-ftc-deal-opens-door-to-more-generic-pesticides/">Corteva admitted no wrongdoing</a>, and the deal still needs a federal judge's approval.</p><p>The check is not the point. The ten years of conduct rules are the point, because they expose the mature end of Corteva's chemistry to competition the program had been holding off. And this is not one company's problem. <a href="https://iowacapitaldispatch.com/2026/09/28/states-ftc-secure-settlement-in-suit-against-corteva-pesticide-loyalty-programs/">Syngenta faces the same FTC case and is still litigating</a>; Corteva is separately settling a related <a href="https://www.agbull.com/cortevas-35-million-ftc-deal-opens-door-to-more-generic-pesticides/">$85 million class action with farmers</a> over the same kind of allegations, announced in June.</p><h2>What actually changes</h2><p>None of this tells you, with certainty, that farmer bills fall. The remedy opens the door; whether cheaper generic supply actually walks through it depends on generic makers showing up, distributors choosing, and rebates not simply reshuffling into a lower list price with the same final cost per treated acre. The settlement guarantees access, not savings.</p> <img data-src="https://imgproxy.citrusreader.com/oBv-V7jJnzPMyVEtF1QkFGWYUhEWw5RZ3VKns0c0yE8/raw:1/aHR0cHM6Ly9jZG4uYWludmVzdC5jb20vYWlnYy9oeGNtcC9pbWFnZXMvY29tcHJlc3MtcXdlbl9nZW5lcmF0ZWRfMTc5MDY0MzE0NTU1OS5qcGcucG5n" style="max-width:100%;" src="https://imgproxy.citrusreader.com/oBv-V7jJnzPMyVEtF1QkFGWYUhEWw5RZ3VKns0c0yE8/raw:1/aHR0cHM6Ly9jZG4uYWludmVzdC5jb20vYWlnYy9oeGNtcC9pbWFnZXMvY29tcHJlc3MtcXdlbl9nZW5lcmF0ZWRfMTc5MDY0MzE0NTU1OS5qcGcucG5n" referrerpolicy="no-referrer"><p>What it does do is settle the direction of pressure on Corteva's mature products. The company now competes on performance, service, and price in a corner of its business where it used to compete mostly on the structure of its discounts. The regulator and the plaintiff bar have jointly announced that they treat the post-patent defense as offside, and Corteva has signed up for a decade of playing by different rules while its largest rival fends off the identical claim.</p><p>For a shareholder the question is not whether $35 million hurts. It is how big the mature, now-exposed slice of that $7.5 billion is, and whether the wider industry's race to defend expired chemistry - which Corteva just paid to exit - was keeping prices higher than the underlying products could support. The check funds the exit. The conduct rules are the ongoing cost, and they land exactly where Corteva's pricing power used to be.</p><visualization data="{&quot;components&quot;:[{&quot;show_type&quot;:&quot;jgyNewLowcode&quot;,&quot;data&quot;:{&quot;columns&quot;:[{&quot;type&quot;:&quot;Object&quot;,&quot;index_name&quot;:&quot;strategy_basic_info&quot;,&quot;key&quot;:&quot;strategy_basic_info&quot;},{&quot;type&quot;:&quot;Object&quot;,&quot;index_name&quot;:&quot;backtest_condition&quot;,&quot;key&quot;:&quot;backtest_condition&quot;},{&quot;type&quot;:&quot;STR&quot;,&quot;index_name&quot;:&quot;backtest_result&quot;,&quot;key&quot;:&quot;backtest_result&quot;}],&quot;datas&quot;:[{&quot;backtest_result&quot;:&quot;https://cdn.ainvest.com/backtest/agent/session/784562/visual-component/e731a18f-bbc6-4368-945e-495ee5d5769d/ctva_backtest_result.json&quot;,&quot;backtest_condition&quot;:{&quot;risk_control&quot;:{&quot;display_name&quot;:&quot;Risk Control&quot;,&quot;parameters&quot;:{&quot;take_profit&quot;:{&quot;unit&quot;:&quot;%&quot;,&quot;display_name&quot;:&quot;Take-Profit&quot;,&quot;value&quot;:8.0},&quot;stop_loss&quot;:{&quot;unit&quot;:&quot;%&quot;,&quot;display_name&quot;:&quot;Stop-Loss&quot;,&quot;value&quot;:4.0},&quot;max_holding_days&quot;:{&quot;display_name&quot;:&quot;Hold Days&quot;,&quot;value&quot;:20}}},&quot;open_signal&quot;:{&quot;criteria&quot;:&quot;RSI(14) < 30&quot;,&quot;display_name&quot;:&quot;Open Signal&quot;,&quot;type&quot;:&quot;criteria&quot;},&quot;sell_signal&quot;:{&quot;criteria&quot;:&quot;RSI(14) > 70 OR 20 days OR TP 8% OR SL 4%&quot;,&quot;display_name&quot;:&quot;Close Signal&quot;,&quot;type&quot;:&quot;criteria&quot;},&quot;object&quot;:{&quot;ticker&quot;:[&quot;CTVA&quot;],&quot;display_name&quot;:&quot;CTVA&quot;,&quot;type&quot;:&quot;ticker&quot;}},&quot;strategy_basic_info&quot;:{&quot;name&quot;:&quot;CTVA RSI Mean Reversion Strategy&quot;,&quot;description&quot;:&quot;Long-only strategy on CTVA entering when RSI(14) < 30 and exiting on RSI(14) > 70, 20-day hold limit, or TP/SL triggers.&quot;}}]},&quot;config&quot;:{&quot;type&quot;:&quot;iwcapp/stockBackTestTool&quot;,&quot;version&quot;:&quot;0.0.3&quot;,&quot;url&quot;:&quot;//cdn.ainvest.com/frontResources/s/foiegras/stockBackTestTool/0.0.3/stockBackTestTool@0.0.3index.js&quot;},&quot;uuid&quot;:&quot;1790643498024_2007e625&quot;}],&quot;page&quot;:{&quot;layout&quot;:{&quot;layout_data&quot;:&quot;[{\&quot;uuid\&quot;: \&quot;1790643498024_2007e625\&quot;, \&quot;show_type\&quot;: \&quot;jgyNewLowcode\&quot;}]&quot;,&quot;layout_mode&quot;:&quot;grid&quot;}}}"></visualization>

2026/9/29
阅读更多

AbbVie's Juvmo Turns an $8.7 Billion Write-Off Into a Payoff. The Stock Barely Cared.

<p>The green light landed and the stock barely moved. Late last week the FDA approved AbbVie's Juvmo (tavapadon) for Parkinson's disease, making it <a href="https://www.fiercepharma.com/pharma/abbvies-cerevel-buyout-delivers-fda-gives-go-ahead-1st-class-juvmo-parkinsons-disease">the first selective D1/D5 receptor agonist</a> cleared for the indication, and <a data-code="ABBV" data-position="stock.1" data-marketid="169" data-stockname="Abbvie" data-type="stock" href="https://www.ainvest.com/news/abbvie-juvmo-turns-8-7-billion-write-payoff-stock-barely-cared-2609/#*f:ABBV:sc*#">AbbVie</a> expects it in U.S. <a data-code="861183" data-position="stock.2" data-marketid="89" data-stockname="Pharmacies (Sub-Industry)" data-type="stock" href="https://www.ainvest.com/news/abbvie-juvmo-turns-8-7-billion-write-payoff-stock-barely-cared-2609/#*f:861183:sc*#">pharmacies</a> in October. On the day the news was public, shares traded up less than a percent. For a drug that was supposed to rescue an $8.7 billion acquisition, that flat line is the story worth reading: the approval clause was already priced, and the investor question that matters moved off the headline months ago.</p> <stock-card dataurl="https://cdn.ainvest.com/news/visual/visual_components/viz_fohogptj.json"></stock-card><p><strong>The deal Wall Street already wrote off.</strong> AbbVie agreed to buy Cerevel Therapeutics in December 2023 for <a href="https://www.biospace.com/fda/abbvie-wins-fda-approval-for-parkinsons-drug-from-8-7b-cerevel-takeover">$8.7 billion</a> and closed the deal in August 2024. The announced reason for the price was emraclidine, <a href="https://www.fiercebiotech.com/biotech/abbvie-takes-35b-hit-after-emraclidines-phase-2-flop-schizophrenia">the shining gem of Cerevel's pipeline</a> - a next-generation schizophrenia drug built to take on Bristol Myers Squibb's Cobenfy. That bet collapsed in November 2024, when emraclidine <a href="https://news.abbvie.com/2024-11-11-AbbVie-Provides-Update-on-Phase-2-Results-for-Emraclidine-in-Schizophrenia">missed its primary endpoint in two Phase 2 trials</a>. AbbVie <a href="https://www.biopharmadive.com/news/abbvie-emraclidine-failure-schizophrenia-bristol-myers-cobenfy/732534/">lost about $40 billion of market value</a> and shares <a href="https://www.biospace.com/drug-development/abbvie-shares-plummet-12-as-cerevel-schizophrenia-asset-fails-phase-ii-trials">fell more than 12% in a single day</a>, and in January the company booked a <a href="https://www.fiercebiotech.com/biotech/abbvie-takes-35b-hit-after-emraclidines-phase-2-flop-schizophrenia">$3.5 billion impairment</a>. Analysts called the acquisition a fire. Cerevel's other big asset - the Parkinson's candidate - had for a year been written off as the <a href="https://www.fiercebiotech.com/biotech/abbvie-bound-cerevel-reports-phase-3-parkinsons-victory-early-win-87b-deal">backing singer in the takeover</a>. That backing singer just received the FDA's approval.</p><p><strong>Why the mechanism matters beyond the "first."</strong> Juvmo is a once-daily pill, taken with or without levodopa, engineered to hit D1/D5 dopamine receptors rather than the D2/D3 receptors that older dopamine agonist drugs mainly target. In the Phase 3 TEMPO program it improved motor symptoms across the Parkinson's spectrum and, added to levodopa in patients with motor fluctuations, added about <a href="https://www.prnewswire.com/news-releases/us-fda-approves-abbvies-juvmo-tavapadon-for-parkinsons-disease-302890715.html">1.7 hours</a> of good "on" time a day versus placebo. The promise AbbVie sells hardest is levodopa sparing: in the long-term extension, 93% of patients on Juvmo <a href="https://www.prnewswire.com/news-releases/us-fda-approves-abbvies-juvmo-tavapadon-for-parkinsons-disease-302890715.html">did not increase their levodopa dose</a>, and a drug that delays levodopa's dose creep attacks the largest source of late-stage complications in the disease. On its Q2 call in July, AbbVie commercial chief Jeffrey Stewart called Parkinson's disease a <a href="https://www.biospace.com/fda/abbvie-wins-fda-approval-for-parkinsons-drug-from-8-7b-cerevel-takeover">$5 billion market opportunity</a>.</p><backtest-component code="ABBV" id="strategy_006" range="3" market="169"></backtest-component><p><strong>Here is the arithmetic worth checking.</strong> That $5 billion is AbbVie's framing, not found money, and it sits at the aggressive end of everyone else's numbers: third-party estimates of the global Parkinson's drug market run from <a href="https://www.delveinsight.com/insights/parkinsons-disease-market-insights">about $3.5 billion a year</a> to <a href="https://www.fortunebusinessinsights.com/industry-reports/parkinson-s-disease-drugs-market-100655">under $8 billion</a>, and no single product consumes a market. The sharpest third-party receipt on Juvmo's value arrived the same day as the approval. Royalty fund DRI Healthcare agreed to <a href="https://finance.yahoo.com/healthcare/articles/dri-healthcare-comments-juvmos-tavapadon-125800501.html">pay $316 million</a> for participation rights in Juvmo's U.S. sales - tiered royalties in the mid-single to low-double digit range - under a hard cap of $437.5 million in total receipts to DRI. Read that backward: a sophisticated investor put up $316 million for a slice of the product with a ceiling of roughly $122 million of upside above what it paid. It is a financing and a yield trade, and its bounded cap is not the vote of confidence a blockbuster narrative usually generates.</p> <visualization data="{&quot;components&quot;:[{&quot;show_type&quot;:&quot;jgyNewLowcode&quot;,&quot;data&quot;:{&quot;columns&quot;:[{&quot;type&quot;:&quot;Object&quot;,&quot;index_name&quot;:&quot;strategy_basic_info&quot;,&quot;key&quot;:&quot;strategy_basic_info&quot;},{&quot;type&quot;:&quot;Object&quot;,&quot;index_name&quot;:&quot;backtest_condition&quot;,&quot;key&quot;:&quot;backtest_condition&quot;},{&quot;type&quot;:&quot;STR&quot;,&quot;index_name&quot;:&quot;backtest_result&quot;,&quot;key&quot;:&quot;backtest_result&quot;}],&quot;datas&quot;:[{&quot;backtest_result&quot;:&quot;https://cdn.ainvest.com/backtest/agent/session/784562/visual-component/e0d611ba-e1de-4215-9738-ccb8b873f173/abbv_manual_backtest.json&quot;,&quot;backtest_condition&quot;:{&quot;risk_control&quot;:{&quot;display_name&quot;:&quot;Risk Control&quot;,&quot;parameters&quot;:{&quot;take_profit&quot;:{&quot;unit&quot;:&quot;%&quot;,&quot;display_name&quot;:&quot;Take-Profit&quot;,&quot;value&quot;:8.0},&quot;stop_loss&quot;:{&quot;unit&quot;:&quot;%&quot;,&quot;display_name&quot;:&quot;Stop-Loss&quot;,&quot;value&quot;:4.0},&quot;max_holding_days&quot;:{&quot;display_name&quot;:&quot;Hold Days&quot;,&quot;value&quot;:20},&quot;max_drawdown&quot;:{&quot;unit&quot;:&quot;%&quot;,&quot;display_name&quot;:&quot;Drawdown&quot;,&quot;value&quot;:20.0}}},&quot;open_signal&quot;:{&quot;criteria&quot;:&quot;RSI(14) < 30&quot;,&quot;display_name&quot;:&quot;Open Signal&quot;,&quot;type&quot;:&quot;criteria&quot;},&quot;sell_signal&quot;:{&quot;criteria&quot;:&quot;Price closes above 20-day SMA, or after 20 trading days, or upon hitting +8% take-profit or -4% stop-loss&quot;,&quot;display_name&quot;:&quot;Close Signal&quot;,&quot;type&quot;:&quot;criteria&quot;},&quot;object&quot;:{&quot;ticker&quot;:[&quot;ABBV&quot;],&quot;display_name&quot;:&quot;ABBV&quot;,&quot;type&quot;:&quot;ticker&quot;}},&quot;strategy_basic_info&quot;:{&quot;name&quot;:&quot;ABBV RSI(14) < 30 Long-Only Strategy&quot;,&quot;description&quot;:&quot;A long-only strategy for ABBV that enters when RSI(14) < 30 and exits when price closes above 20-day SMA, after 20 trading days, or upon hitting +8% take-profit or -4% stop-loss.&quot;}}]},&quot;config&quot;:{&quot;type&quot;:&quot;iwcapp/stockBackTestTool&quot;,&quot;version&quot;:&quot;0.0.3&quot;,&quot;url&quot;:&quot;//cdn.ainvest.com/frontResources/s/foiegras/stockBackTestTool/0.0.3/stockBackTestTool@0.0.3index.js&quot;},&quot;uuid&quot;:&quot;1789809337428_8fb11ec8&quot;}],&quot;page&quot;:{&quot;layout&quot;:{&quot;layout_data&quot;:&quot;[{\&quot;uuid\&quot;: \&quot;1789809337428_8fb11ec8\&quot;, \&quot;show_type\&quot;: \&quot;jgyNewLowcode\&quot;}]&quot;,&quot;layout_mode&quot;:&quot;grid&quot;}}}"></visualization> <fundamentals-card dataurl="https://cdn.ainvest.com/news/visual/visual_components/viz_fohogptj.json"></fundamentals-card><p><strong>What the flat reaction tells a retail holder.</strong> Juvmo is real and checkable - the approval, the mechanism and the trial readouts are all documents a reader can open. But it is also a small piece of a company worth roughly $470 billion that books over $16 billion a quarter, and the market repriced the milestone when the trial data and the filing arrived, not when the FDA's letter did. A single-molecule event rarely moves a mega-cap on approval day; it moves on expectations of sales. The conditions that would break this reading are the ones every launch faces - scripts converting beyond the existing Parkinson's population, tolerability holding up against a label that warns of dyskinesia, hallucinations and impulse-control urges, and Juvmo displacing rather than merely supplementing levodopa. The approval is a receipt that can be verified in minutes; the sales curve is the exhibit that decides who the payoff actually belongs to.</p> <img data-src="https://imgproxy.citrusreader.com/_rbSkjJ9QVtxsmWCCxcjyn-vXzokziC1rMxwsYurIkY/raw:1/aHR0cHM6Ly9jZG4uYWludmVzdC5jb20vYWlnYy9oeGNtcC9pbWFnZXMvY29tcHJlc3MtcXdlbl9nZW5lcmF0ZWRfMTc5MDY1NzczNTc3NS5qcGcucG5n" style="max-width:100%;" src="https://imgproxy.citrusreader.com/_rbSkjJ9QVtxsmWCCxcjyn-vXzokziC1rMxwsYurIkY/raw:1/aHR0cHM6Ly9jZG4uYWludmVzdC5jb20vYWlnYy9oeGNtcC9pbWFnZXMvY29tcHJlc3MtcXdlbl9nZW5lcmF0ZWRfMTc5MDY1NzczNTc3NS5qcGcucG5n" referrerpolicy="no-referrer">

2026/9/29
阅读更多

The $20.7B AMRAAM check isn't just U.S. taxpayers' — allies and RTX shareholders split the bill

<p>On September 28th the Pentagon awarded Raytheon, an <a data-code="RTX" data-position="stock.1" data-marketid="169" data-stockname="RTX" data-type="stock" href="https://www.ainvest.com/news/20-7b-amraam-check-isn-taxpayers-allies-rtx-shareholders-split-bill-2609/#*f:RTX:sc*#">RTX</a> business, <a href="https://www.prnewswire.com/news-releases/rtxs-raytheon-awarded-20-7-billion-multi-year-contract-for-amraam-under-landmark-production-agreement-302891969.html">a contract worth up to $20.7 billion</a> for Advanced Medium-Range Air-to-Air Missiles (AMRAAMs), the largest in the weapon's history. The reflex is to read this as a record bill that American taxpayers are picking up to refill arsenals depleted in Ukraine and the Middle East. The fine print tells a stingier, more interesting story. At signing the government <a href="https://www.war.gov/News/Contracts/Contract/Article/4613098/contracts-for-sept-28-2026/">bound only $154,266,225 in Foreign Military Sales money and $85,715</a> in American appropriations to the deal. The headline cheque is not, mostly, American, and it is not, yet, much of a cheque.</p> <stock-card dataurl="https://cdn.ainvest.com/news/visual/visual_components/viz_5hyy3gwf.json"></stock-card> <img data-src="https://imgproxy.citrusreader.com/4LGGeaQLQ4uuky7Qx2aXdf1ViMNrSrFU3D8AIMsMh0M/raw:1/aHR0cHM6Ly9jZG4uYWludmVzdC5jb20vYWlnYy9oeGNtcC9pbWFnZXMvY29tcHJlc3MtcXdlbl9nZW5lcmF0ZWRfMTc5MDY0MzA1MDg5Mi5qcGcucG5n" style="max-width:100%;" src="https://imgproxy.citrusreader.com/4LGGeaQLQ4uuky7Qx2aXdf1ViMNrSrFU3D8AIMsMh0M/raw:1/aHR0cHM6Ly9jZG4uYWludmVzdC5jb20vYWlnYy9oeGNtcC9pbWFnZXMvY29tcHJlc3MtcXdlbl9nZW5lcmF0ZWRfMTc5MDY0MzA1MDg5Mi5qcGcucG5n" referrerpolicy="no-referrer"><h2>A down payment in foreign cash</h2><p>FMS money is not a subsidy. Under the Arms Export Control Act, allied governments pay the American government for their missiles, and the government pays the contractor; the cash arrives as reimbursement, not grant. So the dollars actually moving belong to the sixteen allied buyers listed on the award - Australia, Japan, Germany, Italy, Kuwait, Britain and the rest - and not to the US Treasury. The $85,715 that Washington did appropriate is a booking artefact. The action is an "undefinitized" fixed-price-incentive one: work is authorised to begin at a provisional billing limit before the full terms and price are settled, and the remaining ceiling is meant to be funded by delivery orders over the five-year contract and its two option years, running to 2033. The award is at once the largest in the program's history and funded, so far, to less than one per cent of its own ceiling.</p><h2>The leg that waits on Washington</h2><p>Where the money actually comes from matters because the ceiling is a promise of volume, not money on deposit, and its eventual size depends mostly on the American share. The target is annual production of at least 1,900 missiles - <a href="https://www.airandspaceforces.com/raytheon-production-amraam-air-force/">a 58% jump over the 1,200 planned in 2024</a> - with the Air Force alone requesting 483 in fiscal 2026. The deal is explicitly provisional: <a href="https://www.reuters.com/business/aerospace-defense/pentagon-awards-rtxs-raytheon-207-billion-contract-amraam-missiles-amid-2026-09-28/">Congress has not yet appropriated the money behind the full multi-year commitment</a>. That American leg is bound up in the reconciliation fight. AMRAAM sits in the roughly $40bn "legacy munitions" slice of <a href="https://breakingdefense.com/2026/05/heres-whats-at-risk-if-the-pentagons-350b-reconciliation-gambit-fails/">the Pentagon's $350bn industrial-base request</a>, which has slipped off the calendar. <a href="https://www.airandspaceforces.com/house-passes-2027-ndaa-reconciliation-package/">The House passed a $95bn third reconciliation package in July</a>; <a href="https://www.kcra.com/article/senate-budget-reconciliation-30/73264846">Senate leaders say they lack the votes before the recess</a>, and the chamber's top Republican appropriators had already concluded in June that <a href="https://federalnewsnetwork.com/congress/2026/06/top-republican-appropriators-say-third-reconciliation-bill-is-not-an-option/">a third bill was not an option</a>. Annual appropriations buy order-level demand; only the reconciliation surge converts the framework into the sustained ramp the headline implies.</p><backtest-component code="RTX" id="strategy_001" range="3" market="169"></backtest-component><h2>What co-production changes</h2><p>The third partner in the split is not a payer but a shadow. The co-production agreement signed at the NATO summit in Ankara in July commits Raytheon and allied governments to <a href="https://www.rtx.com/news/news-center/2026/07/07/rtx-nato-advance-major-expansion-of-amraam-production-capacity">feasibility studies, funded by participating allies</a>, to qualify European suppliers for priority AMRAAM components - a first step toward building the missile's components on European soil. RTX keeps the prime contract, the design and the order flow; what shifts is where value is added and who pays for the capacity. Every component moved to Europe nudges the bill further from the US budget and cements an allied and co-producer stake in a weapon that would once have been an American export.</p><h2>The shareholder's stake</h2><visualization data="{&quot;components&quot;:[{&quot;show_type&quot;:&quot;jgyNewLowcode&quot;,&quot;data&quot;:{&quot;columns&quot;:[{&quot;type&quot;:&quot;Object&quot;,&quot;index_name&quot;:&quot;strategy_basic_info&quot;,&quot;key&quot;:&quot;strategy_basic_info&quot;},{&quot;type&quot;:&quot;Object&quot;,&quot;index_name&quot;:&quot;backtest_condition&quot;,&quot;key&quot;:&quot;backtest_condition&quot;},{&quot;type&quot;:&quot;STR&quot;,&quot;index_name&quot;:&quot;backtest_result&quot;,&quot;key&quot;:&quot;backtest_result&quot;}],&quot;datas&quot;:[{&quot;backtest_result&quot;:&quot;https://cdn.ainvest.com/backtest/agent/session/784562/visual-component/6b15a17c-b9de-4fa4-bc6a-8910bb8e6b56/rtx_backtest_results.json&quot;,&quot;backtest_condition&quot;:{&quot;risk_control&quot;:{&quot;display_name&quot;:&quot;Risk Control&quot;,&quot;parameters&quot;:{&quot;take_profit&quot;:{&quot;unit&quot;:&quot;%&quot;,&quot;display_name&quot;:&quot;Take-Profit&quot;,&quot;value&quot;:8},&quot;stop_loss&quot;:{&quot;unit&quot;:&quot;%&quot;,&quot;display_name&quot;:&quot;Stop-Loss&quot;,&quot;value&quot;:4},&quot;max_holding_days&quot;:{&quot;display_name&quot;:&quot;Hold Days&quot;,&quot;value&quot;:20}}},&quot;open_signal&quot;:{&quot;criteria&quot;:&quot;RSI(14) crosses above 50&quot;,&quot;display_name&quot;:&quot;Open Signal&quot;,&quot;type&quot;:&quot;criteria&quot;},&quot;sell_signal&quot;:{&quot;criteria&quot;:&quot;Price closes below 20-day SMA&quot;,&quot;display_name&quot;:&quot;Close Signal&quot;,&quot;type&quot;:&quot;criteria&quot;},&quot;object&quot;:{&quot;ticker&quot;:[&quot;RTX&quot;],&quot;display_name&quot;:&quot;RTX&quot;,&quot;type&quot;:&quot;ticker&quot;}},&quot;strategy_basic_info&quot;:{&quot;name&quot;:&quot;RSI 50 Cross &amp; SMA 20 Exit Strategy&quot;,&quot;description&quot;:&quot;Long-only strategy on RTX entering when RSI(14) crosses above 50 and exiting when price closes below 20-day SMA, or after 20 days, or upon hitting TP/SL.&quot;}}]},&quot;config&quot;:{&quot;type&quot;:&quot;iwcapp/stockBackTestTool&quot;,&quot;version&quot;:&quot;0.0.3&quot;,&quot;url&quot;:&quot;//cdn.ainvest.com/frontResources/s/foiegras/stockBackTestTool/0.0.3/stockBackTestTool@0.0.3index.js&quot;},&quot;uuid&quot;:&quot;1789797759641_082c2503&quot;}],&quot;page&quot;:{&quot;layout&quot;:{&quot;layout_data&quot;:&quot;[{\&quot;uuid\&quot;: \&quot;1789797759641_082c2503\&quot;, \&quot;show_type\&quot;: \&quot;jgyNewLowcode\&quot;}]&quot;,&quot;layout_mode&quot;:&quot;grid&quot;}}}"></visualization><p>For RTX shareholders the record headline says nothing about margin, and margin is the question. A sole-source, mature missile in acute demand, bought in multiyear volume with a customer that helps fund the capacity, is a rare cash engine; the framework agreements under which this award falls use a "collaborative funding approach <a href="https://www.rtx.com/news/news-center/2026/02/04/rtxs-raytheon-partners-with-department-of-war-on-five-landmark-agreements-to-exp">designed to preserve RTX's upfront free cash flow</a>," and RTX's operating margin already runs near 10%. The engine's certainty now rests on the American leg, because RTX is being asked to spend on workforce, supply chain and facilities before the appropriations arrive. The market has already priced the doubt: the shares have fallen roughly 11% over the past month and barely moved on the announcement itself. The variable that decides whether $20.7bn becomes revenue is not the award - the framework that produced it was signed in February - but whether Congress funds its share of the surge. Until that vote lands, the record cheque is an allied down payment on an American ambition.</p> <fundamentals-card dataurl="https://cdn.ainvest.com/news/visual/visual_components/viz_5hyy3gwf.json"></fundamentals-card> <visualization dataurl="https://cdn.ainvest.com/news/visual/visual_components/viz_uidixc54.json"></visualization>

2026/9/29
阅读更多

Sweetgreen's post-cyclospora rally prices in a recovery it hasn't reported yet

<p>Sweetgreen shares pushed higher on Monday after <a data-code="WFC" data-position="stock.1" data-marketid="169" data-stockname="Wells Fargo" data-type="stock" href="https://www.ainvest.com/news/sweetgreen-post-cyclospora-rally-prices-recovery-hasn-reported-2609/#*f:WFC:sc*#">Wells Fargo</a> upgraded the salad chain, capping a rebound that has erased the summer slump tied to the cyclospora food-safety scare. The instinctive read is simple: the crisis that crushed the stock is over, so the bad news is behind and the wounded business is now a bargain. That read gets the crisis right and the bargain wrong.</p><p>Wells Fargo lifted <a href="https://www.investing.com/news/stock-market-news/sweetgreen-shares-erase-cyclospora-slump-as-wells-fargo-upgrades-4920949">Sweetgreen to Overweight from Equal Weight</a>, setting a price target of $11 that implies roughly <a href="https://www.investing.com/news/stock-market-news/sweetgreen-shares-erase-cyclospora-slump-as-wells-fargo-upgrades-4920949">34% upside from Friday's close</a>. The bull case names the right things - fading cyclospora headwinds, menu innovation, operational fixes. But look at what the target is actually built on. It values the business at about <a href="https://www.investing.com/news/stock-market-news/sweetgreen-shares-erase-cyclospora-slump-as-wells-fargo-upgrades-4920949">18x projected fiscal 2028 EBITDA</a>, plus <a href="https://www.investing.com/news/stock-market-news/sweetgreen-shares-erase-cyclospora-slump-as-wells-fargo-upgrades-4920949">$2 a share for Sweetgreen's stake in Wonder</a>. That is not a price set against today's earnings; the company is losing money and guides to more of it this year. It is a price parked two fiscal years out, on the assumption that a recovery analysts expect will actually show up.</p> <analyst-card dataurl="https://cdn.ainvest.com/news/visual/visual_components/viz_mijk5frq.json"></analyst-card><h2>The shock was real, and so is <a data-code="GAP" data-position="stock.3" data-marketid="169" data-stockname="The Gap" data-type="stock" href="https://www.ainvest.com/news/sweetgreen-post-cyclospora-rally-prices-recovery-hasn-reported-2609/#*f:GAP:sc*#">the gap</a> to the price</h2><p>The recovery story deserves credit on its own terms. <a data-code="SG" data-position="stock.2" data-marketid="169" data-stockname="Sweetgreen" data-type="stock" href="https://www.ainvest.com/news/sweetgreen-post-cyclospora-rally-prices-recovery-hasn-reported-2609/#*f:SG:sc*#">Sweetgreen</a> was never implicated in the cyclospora outbreak - it <a href="https://www.cnbc.com/2026/08/06/sweetgreen-cuts-full-year-outlook-as-cyclospora-fears-weigh-on-sales.html">does not serve iceberg lettuce</a>, the item the FDA tied to the illness - and the CDC declared the episode <a href="https://www.briefs.co/news/sweetgreen-stock-pops-after-wells-fargo-upgrade-on-faster-cy/">ended on September 11</a> with a different chain as the source. The damage was consumer sentiment about fresh leafy greens, not a Sweetgreen failure, the kind of external, transitory shock a brand can outgrow. Industry channel checks pointed to traffic turning in September.</p><backtest-component code="SG" id="event_001" range="3" market="169"></backtest-component> <img data-src="https://imgproxy.citrusreader.com/RUaJJowUXy0288i8Z9bxeeQv59yAdpmeDXagDqRjRbY/raw:1/aHR0cHM6Ly9jZG4uYWludmVzdC5jb20vYWlnYy9oeGNtcC9pbWFnZXMvY29tcHJlc3MtcXdlbl9nZW5lcmF0ZWRfMTc5MDY0MzEyMjYzNS5qcGcucG5n" style="max-width:100%;" src="https://imgproxy.citrusreader.com/RUaJJowUXy0288i8Z9bxeeQv59yAdpmeDXagDqRjRbY/raw:1/aHR0cHM6Ly9jZG4uYWludmVzdC5jb20vYWlnYy9oeGNtcC9pbWFnZXMvY29tcHJlc3MtcXdlbl9nZW5lcmF0ZWRfMTc5MDY0MzEyMjYzNS5qcGcucG5n" referrerpolicy="no-referrer"><p>What makes the setup uncomfortable is how far the stock has already traveled on that expectation. Sweetgreen has climbed <a href="https://www.briefs.co/news/sweetgreen-stock-pops-after-wells-fargo-upgrade-on-faster-cy/">more than 60% from its August 11 low</a> before a single quarter has confirmed the recovery. And the base it is recovering toward was already weak. Before cyclospora hit the headlines, the chain was fighting to stop the slide: same-store sales fell about <a href="https://www.nrn.com/fast-casual/sweetgreen-downgrades-guidance-despite-improving-trends">13% in the first quarter</a> - the worst since it went public - and were still <a href="https://www.nrn.com/fast-casual/sweetgreen-downgrades-guidance-despite-improving-trends">down 6.2% in the second</a>, improving only as guests traded down to cheaper wraps. The outbreak then added an estimated <a href="https://www.nrn.com/fast-casual/sweetgreen-downgrades-guidance-despite-improving-trends">600 basis points</a> of comparable-sales pressure through the summer.</p><p>Today's guidance shows how much proof is still missing. Sweetgreen now expects <a href="https://www.cnbc.com/2026/08/06/sweetgreen-cuts-full-year-outlook-as-cyclospora-fears-weigh-on-sales.html">same-store sales to fall 7% to 8% this year</a>, a deep cut from the 2% to 4% decline it projected in May, and guides to an <a href="https://www.cnbc.com/2026/08/06/sweetgreen-cuts-full-year-outlook-as-cyclospora-fears-weigh-on-sales.html">adjusted EBITDA loss of $23 million to $27 million</a>. <a href="https://www.nrn.com/fast-casual/sweetgreen-downgrades-guidance-despite-improving-trends">Net loss widened to $26.3 million</a>. The chain's balance sheet holds roughly $143 million of cash against a trailing-twelve-month free cash outflow of more than $120 million, a reminder that funding new <a data-code="861170" data-position="stock.4" data-marketid="89" data-stockname="Restaurants (Sub-Industry)" data-type="stock" href="https://www.ainvest.com/news/sweetgreen-post-cyclospora-rally-prices-recovery-hasn-reported-2609/#*f:861170:sc*#">restaurants</a> while sales shrink is not a comfortable place to sit.</p> <visualization data="{&quot;components&quot;:[{&quot;show_type&quot;:&quot;jgyNewLowcode&quot;,&quot;data&quot;:{&quot;columns&quot;:[{&quot;type&quot;:&quot;Object&quot;,&quot;index_name&quot;:&quot;strategy_basic_info&quot;,&quot;key&quot;:&quot;strategy_basic_info&quot;},{&quot;type&quot;:&quot;Object&quot;,&quot;index_name&quot;:&quot;backtest_condition&quot;,&quot;key&quot;:&quot;backtest_condition&quot;},{&quot;type&quot;:&quot;STR&quot;,&quot;index_name&quot;:&quot;backtest_result&quot;,&quot;key&quot;:&quot;backtest_result&quot;}],&quot;datas&quot;:[{&quot;backtest_result&quot;:&quot;https://cdn.ainvest.com/backtest/agent/session/784562/visual-component/3d72af57-f4d2-4170-a0f2-daf2886ff251/sgx_backtest_result.json&quot;,&quot;backtest_condition&quot;:{&quot;risk_control&quot;:{&quot;display_name&quot;:&quot;Risk Control&quot;,&quot;parameters&quot;:{&quot;take_profit&quot;:{&quot;unit&quot;:&quot;%&quot;,&quot;display_name&quot;:&quot;Take-Profit&quot;,&quot;value&quot;:8},&quot;stop_loss&quot;:{&quot;unit&quot;:&quot;%&quot;,&quot;display_name&quot;:&quot;Stop-Loss&quot;,&quot;value&quot;:4},&quot;max_holding_days&quot;:{&quot;display_name&quot;:&quot;Hold Days&quot;,&quot;value&quot;:20}}},&quot;open_signal&quot;:{&quot;criteria&quot;:&quot;Price breaks above the 20-day Donchian high&quot;,&quot;display_name&quot;:&quot;Open Signal&quot;,&quot;type&quot;:&quot;criteria&quot;},&quot;sell_signal&quot;:{&quot;criteria&quot;:&quot;Price closes below the 50-day SMA, or TP +8%, SL -4%, or Max 20 days&quot;,&quot;display_name&quot;:&quot;Close Signal&quot;,&quot;type&quot;:&quot;criteria&quot;},&quot;object&quot;:{&quot;ticker&quot;:[&quot;SGX.SI&quot;],&quot;display_name&quot;:&quot;SGX.SI&quot;,&quot;type&quot;:&quot;ticker&quot;}},&quot;strategy_basic_info&quot;:{&quot;name&quot;:&quot;SGX Donchian Breakout Strategy&quot;,&quot;description&quot;:&quot;Long-only strategy on SGX.SI. Entry: Price > 20-day Donchian High. Exit: Close < 50-day SMA, TP +8%, SL -4%, Max Hold 20 days.&quot;}}]},&quot;config&quot;:{&quot;type&quot;:&quot;iwcapp/stockBackTestTool&quot;,&quot;version&quot;:&quot;0.0.3&quot;,&quot;url&quot;:&quot;//cdn.ainvest.com/frontResources/s/foiegras/stockBackTestTool/0.0.3/stockBackTestTool@0.0.3index.js&quot;},&quot;uuid&quot;:&quot;1790643430106_4b77aa4e&quot;}],&quot;page&quot;:{&quot;layout&quot;:{&quot;layout_data&quot;:&quot;[{\&quot;uuid\&quot;: \&quot;1790643430106_4b77aa4e\&quot;, \&quot;show_type\&quot;: \&quot;jgyNewLowcode\&quot;}]&quot;,&quot;layout_mode&quot;:&quot;grid&quot;}}}"></visualization> <fundamentals-card dataurl="https://cdn.ainvest.com/news/visual/visual_components/viz_mijk5frq.json"></fundamentals-card> <h2>The proof lands next quarter</h2><p>That gap between price and proof is the whole question. For the $11 target to work, comparable sales have to inflect positive in fiscal 2027 and EBITDA has to swing from a loss this year to the positive level an 18x multiple assumes two years out. The stock has already moved most of the way toward that outcome, so buying at $8 means paying for a recovery as though it has succeeded.</p> <stock-card dataurl="https://cdn.ainvest.com/news/visual/visual_components/viz_mijk5frq.json"></stock-card><p>The referee is the next quarterly report. If third-quarter comps <a data-code="SNAP" data-position="stock.5" data-marketid="169" data-stockname="Snap" data-type="stock" href="https://www.ainvest.com/news/sweetgreen-post-cyclospora-rally-prices-recovery-hasn-reported-2609/#*f:SNAP:sc*#">snap</a> back toward flat, near the pre-outbreak baseline the channel checks suggest, the thesis gains real evidence and the rally looks fair. If they stay deeply negative, or the EBITDA loss comes in at the bad end of the range, then the market priced the turnaround before the company delivered it. A separate ingredient is worth watching too: Sweetgreen pulled some jalapeños in a voluntary recall tied to a salmonella scare, exposure it downplayed as <a href="https://www.morningstar.com/news/marketwatch/20260806440/sweetgreen-recalls-jalapenos-details-how-cyclospora-outbreak-will-weigh-on-sales">limited to two of its dressings</a>.</p><p>The cleanest summary is that the crisis is over but the discount is not. The cheap entry was the summer low; at $8 the stock is a bet that 2027 and 2028 execution beats the street, not a bargain-bin pickup. The evidence that decides it arrives with the third-quarter numbers - and there is no reason to pay today for a proof window that is only weeks away.</p>

2026/9/29
阅读更多

Cleveland-Cliffs' 8% Drop Is About the $5.6 Billion Antitrust Sword, Not the New Iowa Mill

<p>Cleveland-Cliffs (NYSE: CLF) gave back a week's worth of gains in a single session on Monday, closing at $11.22 after falling almost 8% on sharply higher volume. The trigger was political theater: President Donald Trump stood alongside <a data-code="MSB" data-position="stock.4" data-marketid="169" data-stockname="Mesabi Trust" data-type="stock" href="https://www.ainvest.com/news/cleveland-cliffs-8-drop-5-6-billion-antitrust-sword-iowa-mill-2609/#*f:MSB:sc*#">Mesabi</a> Metallics to unveil <a href="https://www.reuters.com/business/trump-unveil-planned-15-billion-iowa-steel-project-2026-09-28/">a planned $15 billion steel mill</a> in eastern Iowa, a rival project celebrated as a win for American manufacturing. For a Cliffs shareholder watching the news, the sell-off looked like a competitor entering the room. The timing tells a different story, and so does the identity of the company making the announcement.</p> <stock-card dataurl="https://cdn.ainvest.com/news/visual/visual_components/viz_dgefzbqn.json"></stock-card><h3>A 2030 project, a 2026 sell-off</h3><p>The Iowa mill is a genuine competitive event, but it is one measured in years, not quarters. On full build-out it would produce as much as 10 million tons of <a data-code="861317" data-position="stock.3" data-marketid="89" data-stockname="Steel (Industry)" data-type="stock" href="https://www.ainvest.com/news/cleveland-cliffs-8-drop-5-6-billion-antitrust-sword-iowa-mill-2609/#*f:861317:sc*#">steel</a> a year - <a href="https://www.mprnews.org/story/2026/09/28/ore-from-mesabi-metallics-mine-will-be-used-for-15-billion-steel-mill-planed-for-iowa">more than any other U.S. steel plant</a> - yet it is <a href="https://www.mprnews.org/story/2026/09/28/ore-from-mesabi-metallics-mine-will-be-used-for-15-billion-steel-mill-planed-for-iowa">not expected to begin producing until around 2030</a>, and its ore would come from a brand-new Mesabi mine that <a href="https://www.mprnews.org/story/2026/09/28/ore-from-mesabi-metallics-mine-will-be-used-for-15-billion-steel-mill-planed-for-iowa">only opened this September</a>. A facility that does not exist yet does not touch Cliffs' 2026 or 2027 income statement.</p><p>That is the first clue that the headline was acceleration, not cause. The stock had already turned down three sessions earlier, peaking around September 23, and steel-sector sentiment had soured on weakening demand before any White House announcement. Monday's gap simply stamped an existing rollover with a reason. The volume behind it - turnover of roughly $300 million on the day - says sellers were willing to step forward, not that a panic was manufactured out of nothing.</p><backtest-component code="CLF" id="strategy_002" range="3" market="169"></backtest-component><h3>The number the headline buries</h3><p>Mesabi is not a stranger to Cliffs; it is the company that has been suing Cliffs for years. In that case Mesabi is <a href="https://www.mesabimetallics.com/cleveland-cliffs-to-face-jury-trial-in-multibillion-dollar-mesabi-metallics-antitrust-suit/">seeking up to $5.6 billion in damages</a>, a figure that dwarfs the storyline of a future competitor. It is worth putting that number in scale: at roughly $6.4 billion, it would erase nearly the entire market cap, and it is equal to about 97% of the company's $5.8 billion of equity. In the case, a court has issued a summary-judgment finding that <a href="https://www.mesabimetallics.com/cleveland-cliffs-to-face-jury-trial-in-multibillion-dollar-mesabi-metallics-antitrust-suit/">Cleveland-Cliffs was a monopolist in the market for blast furnace pellets in the Great Lakes region</a>, a finding that remains in place as the dispute is <a href="https://www.mesabimetallics.com/cleveland-cliffs-to-face-jury-trial-in-multibillion-dollar-mesabi-metallics-antitrust-suit/">set for a jury trial</a>. The $15 billion mill grabs the headline; the up-to-$5.6 billion award that could actually detonate is the risk the price is really marking.</p><h3>Where the setup stands</h3><p>At $11.22 the stock is testing the low-$11 shelf, under a low-to-mid-$12 resistance band it pushed above during the summer rally that reclaimed its 50- and 200-day averages in late July. Because the stock fell three days into Monday's volume-confirmed gap, this reads as a breakdown in progress rather than a fresh panic bottom. For a trader the levels are clean: a close below Monday's low near $11.00 confirms the move, with the round $10 figure as the first objective - roughly 11% from here - and the $9 zone, home of the spring base, if selling extends. A close back above the low-$12s, near $12.25, about 9% above the close, would void the bearish reading.</p><visualization data="{&quot;components&quot;:[{&quot;show_type&quot;:&quot;jgyNewLowcode&quot;,&quot;data&quot;:{&quot;columns&quot;:[{&quot;type&quot;:&quot;Object&quot;,&quot;index_name&quot;:&quot;strategy_basic_info&quot;,&quot;key&quot;:&quot;strategy_basic_info&quot;},{&quot;type&quot;:&quot;Object&quot;,&quot;index_name&quot;:&quot;backtest_condition&quot;,&quot;key&quot;:&quot;backtest_condition&quot;},{&quot;type&quot;:&quot;STR&quot;,&quot;index_name&quot;:&quot;backtest_result&quot;,&quot;key&quot;:&quot;backtest_result&quot;}],&quot;datas&quot;:[{&quot;backtest_result&quot;:&quot;https://cdn.ainvest.com/backtest/agent/session/784562/visual-component/41dc9e72-f2a4-403b-86ac-3893430c5f90/clf_backtest_results.json&quot;,&quot;backtest_condition&quot;:{&quot;risk_control&quot;:{&quot;display_name&quot;:&quot;Risk Control&quot;,&quot;parameters&quot;:{&quot;take_profit&quot;:{&quot;unit&quot;:&quot;%&quot;,&quot;display_name&quot;:&quot;Take-Profit&quot;,&quot;value&quot;:8.0},&quot;stop_loss&quot;:{&quot;unit&quot;:&quot;%&quot;,&quot;display_name&quot;:&quot;Stop-Loss&quot;,&quot;value&quot;:4.0},&quot;max_holding_days&quot;:{&quot;display_name&quot;:&quot;Hold Days&quot;,&quot;value&quot;:20}}},&quot;open_signal&quot;:{&quot;criteria&quot;:&quot;Price closes above the 50-day Simple Moving Average&quot;,&quot;display_name&quot;:&quot;Open Signal&quot;,&quot;type&quot;:&quot;criteria&quot;},&quot;sell_signal&quot;:{&quot;criteria&quot;:&quot;Price closes below the 200-day Simple Moving Average, or after 20 trading days, or upon reaching take-profit (+8%) or stop-loss (-4%) levels&quot;,&quot;display_name&quot;:&quot;Close Signal&quot;,&quot;type&quot;:&quot;criteria&quot;},&quot;object&quot;:{&quot;ticker&quot;:[&quot;CLF&quot;],&quot;display_name&quot;:&quot;CLF&quot;,&quot;type&quot;:&quot;ticker&quot;}},&quot;strategy_basic_info&quot;:{&quot;name&quot;:&quot;CLF Long-Only SMA Crossover Strategy&quot;,&quot;description&quot;:&quot;A long-only strategy for CLF that enters when price closes above the 50-day SMA and exits when price closes below the 200-day SMA, or after 20 trading days, or upon reaching take-profit (+8%) or stop-loss (-4%) levels.&quot;}}]},&quot;config&quot;:{&quot;type&quot;:&quot;iwcapp/stockBackTestTool&quot;,&quot;version&quot;:&quot;0.0.3&quot;,&quot;url&quot;:&quot;//cdn.ainvest.com/frontResources/s/foiegras/stockBackTestTool/0.0.3/stockBackTestTool@0.0.3index.js&quot;},&quot;uuid&quot;:&quot;1789771908414_e12a9baa&quot;}],&quot;page&quot;:{&quot;layout&quot;:{&quot;layout_data&quot;:&quot;[{\&quot;uuid\&quot;: \&quot;1789771908414_e12a9baa\&quot;, \&quot;show_type\&quot;: \&quot;jgyNewLowcode\&quot;}]&quot;,&quot;layout_mode&quot;:&quot;grid&quot;}}}"></visualization> <technology-card dataurl="https://cdn.ainvest.com/news/visual/visual_components/viz_dgefzbqn.json"></technology-card><p>The two resolved benchmarks are close enough that the setup is near-balance until one side prints. What decides which side deserves weight is not another line on the chart but the valuation underneath it. This is a money-losing, heavily levered manufacturer - about $7.6 billion of net debt against a $14 billion enterprise value, negative trailing net income, an EV-to-EBITDA multiple near 50 times, and a beta above 2. A company with those economics compresses violently on a negative headline, which is exactly why the downside confirmation deserves real credit rather than dismissal as noise.</p> <fundamentals-card dataurl="https://cdn.ainvest.com/news/visual/visual_components/viz_dgefzbqn.json"></fundamentals-card><p>That is what the crowd is missing. The retail news feed is full of the Iowa mill, a story that only matures around 2030. The price is already debating the $5.6 billion damage ceiling and the debt load - risks that are live now. The next genuine catalyst is the third-quarter report due in late October, where analysts have penciled in a move back toward break-even after the company lost about $0.20 per share in the second quarter. Until a close picks a side of the $11 shelf, the honest answer to "what now" is to wait for the level: the mill is background, the lawsuit is the bet, and the tape has not yet said which one wins.</p> <analyst-card dataurl="https://cdn.ainvest.com/news/visual/visual_components/viz_dgefzbqn.json"></analyst-card> <img data-src="https://imgproxy.citrusreader.com/Za6I42AtVaaOQlEw6YKyCll9UQg4K4VK7vTj_HfrJGY/raw:1/aHR0cHM6Ly9jZG4uYWludmVzdC5jb20vYWlnYy9oeGNtcC9pbWFnZXMvY29tcHJlc3MtcXdlbl9nZW5lcmF0ZWRfMTc5MDY1NzcxNDczMy5qcGcucG5n" style="max-width:100%;" src="https://imgproxy.citrusreader.com/Za6I42AtVaaOQlEw6YKyCll9UQg4K4VK7vTj_HfrJGY/raw:1/aHR0cHM6Ly9jZG4uYWludmVzdC5jb20vYWlnYy9oeGNtcC9pbWFnZXMvY29tcHJlc3MtcXdlbl9nZW5lcmF0ZWRfMTc5MDY1NzcxNDczMy5qcGcucG5n" referrerpolicy="no-referrer">

2026/9/29
阅读更多

Coinbase's new clearinghouse is a USDC factory, not a fee play

<p>On September 28 the Commodity Futures Trading Commission registered <a data-code="COIN" data-position="stock.1" data-marketid="185" data-stockname="Coinbase Global" data-type="stock" href="https://www.ainvest.com/news/coinbase-clearinghouse-usdc-factory-fee-play-2609/#*f:COIN:sc*#">Coinbase</a> Clearing LLC as a derivatives clearing organization, making it the <a href="https://www.coinbase.com/blog/coinbase-receives-cftc-approval-for-coinbase-clearing-llc">first USDC-native clearinghouse</a>. The application had sat on the CFTC's pending list since November 2025, and the approval closes the final gap in Coinbase's US derivatives plumbing. Coinbase has held the exchange license for years through Coinbase Derivatives, a federally designated contract market; what it lacked was the clearinghouse that stands in the middle of every trade, holds the margin, and eats the default. Until now that job belonged to <a href="https://www.cftc.gov/IndustryOversight/IndustryFilings/TradingOrganizations/43304">Nodal Clear, a clearinghouse owned by Deutsche Börse's EEX Group</a>.</p> <stock-card dataurl="https://cdn.ainvest.com/news/visual/visual_components/viz_gjorwmyr.json"></stock-card><p>The obvious reading is that Coinbase just cut out a fee-charging middleman and took another slice of the derivatives market for itself. The approval turns out to be narrower than that - and the narrowness is the story.</p><h2>The book it's allowed to clear</h2><p>The new clearinghouse can clear only <a href="https://thedefiant.io/converge/tradfi-and-fintech/coinbase-wins-cftc-approval-for-in-house-derivatives-clearing">fully collateralized contracts</a>, meaning every position is backed one-for-one with no leverage. Coinbase has said it will keep outside clearing partners for the margined futures it offers and for the perpetual single-stock futures it has in development.</p><backtest-component code="COIN" id="strategy_006" range="3" market="185"></backtest-component><p>That scope constraint is the tell. In traditional clearing, a central counterparty's economics come from leverage - you are paid for the risk you intermediate and the margin you hold. A fully collateralized book carries almost none of that, so on a fee-per-contract basis it is the least profitable thing a clearinghouse could take in-house. Coinbase is not doing this for the clearing fee. It is doing it for the collateral.</p><h2>A <a data-code="USDCUSDT" data-position="stock.6" data-marketid="UBAX" data-stockname="USDC" data-coinbase="USDC" data-type="crypto" href="https://www.ainvest.com/news/coinbase-clearinghouse-usdc-factory-fee-play-2609/#*f:USDCUSDT:sc*#">USDC</a> factory, not a fee play</h2><p>Everything the new rail settles and margins in is USDC, and USDC is where Coinbase's economics already live. Legacy clearing pushes margin through banking rails that close nights and weekends; USDC <a href="https://finance.yahoo.com/markets/crypto/articles/cftc-approves-coinbase-clearing-first-001000780.html">settles on-chain around the clock</a>, so a margin call never has to wait for a bank to open - a real feature in a market whose sharpest moves land on Sunday nights. But the bigger prize is the <a data-code="SDEV" data-position="stock.3" data-marketid="170" data-stockname="Stablecoin" data-type="stock" href="https://www.ainvest.com/news/coinbase-clearinghouse-usdc-factory-fee-play-2609/#*f:SDEV:sc*#">stablecoin</a> itself. Over the past year Coinbase has captured <a href="https://investor.coinbase.com/news/news-details/2026/Coinbase-Q2-Earnings-Everything-Exchange-Drives-3rd-Consecutive-Quarter-of-Record-Crypto-Trading-Volume-Market-Share-Revenue-Diversification-and-Resilience/default.aspx">about half of all USDC economics</a>, and at the end of the second quarter, USDC held in its products stood at more than thirty percent of everything in circulation. A USDC-native clearinghouse turns every cleared US futures trade into USDC float earning yield inside the Coinbase system. The clearinghouse is a demand engine for that float; the clearing fee is the cover story.</p><visualization data="{&quot;components&quot;:[{&quot;show_type&quot;:&quot;jgyNewLowcode&quot;,&quot;data&quot;:{&quot;columns&quot;:[{&quot;type&quot;:&quot;Object&quot;,&quot;index_name&quot;:&quot;strategy_basic_info&quot;,&quot;key&quot;:&quot;strategy_basic_info&quot;},{&quot;type&quot;:&quot;Object&quot;,&quot;index_name&quot;:&quot;backtest_condition&quot;,&quot;key&quot;:&quot;backtest_condition&quot;},{&quot;type&quot;:&quot;STR&quot;,&quot;index_name&quot;:&quot;backtest_result&quot;,&quot;key&quot;:&quot;backtest_result&quot;}],&quot;datas&quot;:[{&quot;backtest_result&quot;:&quot;https://cdn.ainvest.com/backtest/agent/session/784562/visual-component/b9db7fcf-a214-4fee-9062-83e4cc07a831/coin_backtest_result.json&quot;,&quot;backtest_condition&quot;:{&quot;risk_control&quot;:{&quot;display_name&quot;:&quot;Risk Control&quot;,&quot;parameters&quot;:{&quot;take_profit&quot;:{&quot;unit&quot;:&quot;%&quot;,&quot;display_name&quot;:&quot;Take-Profit&quot;,&quot;value&quot;:8.0},&quot;stop_loss&quot;:{&quot;unit&quot;:&quot;%&quot;,&quot;display_name&quot;:&quot;Stop-Loss&quot;,&quot;value&quot;:4.0},&quot;max_holding_days&quot;:{&quot;display_name&quot;:&quot;Hold Days&quot;,&quot;value&quot;:20}}},&quot;open_signal&quot;:{&quot;criteria&quot;:&quot;Price closes above the 20-day Simple Moving Average&quot;,&quot;display_name&quot;:&quot;Open Signal&quot;,&quot;type&quot;:&quot;criteria&quot;},&quot;sell_signal&quot;:{&quot;criteria&quot;:&quot;Price closes below the 50-day Simple Moving Average&quot;,&quot;display_name&quot;:&quot;Close Signal&quot;,&quot;type&quot;:&quot;criteria&quot;},&quot;object&quot;:{&quot;ticker&quot;:[&quot;COIN&quot;],&quot;display_name&quot;:&quot;COIN&quot;,&quot;type&quot;:&quot;ticker&quot;}},&quot;strategy_basic_info&quot;:{&quot;name&quot;:&quot;COIN 20/50 SMA Crossover Strategy&quot;,&quot;description&quot;:&quot;A long-only strategy that enters when COIN's closing price exceeds the 20-day SMA and exits when it falls below the 50-day SMA, with additional risk controls including an 8% take-profit, 4% stop-loss, and a maximum holding period of 20 trading days.&quot;}}]},&quot;config&quot;:{&quot;type&quot;:&quot;iwcapp/stockBackTestTool&quot;,&quot;version&quot;:&quot;0.0.3&quot;,&quot;url&quot;:&quot;//cdn.ainvest.com/frontResources/s/foiegras/stockBackTestTool/0.0.3/stockBackTestTool@0.0.3index.js&quot;},&quot;uuid&quot;:&quot;1789727597241_fb7726b9&quot;}],&quot;page&quot;:{&quot;layout&quot;:{&quot;layout_data&quot;:&quot;[{\&quot;uuid\&quot;: \&quot;1789727597241_fb7726b9\&quot;, \&quot;show_type\&quot;: \&quot;jgyNewLowcode\&quot;}]&quot;,&quot;layout_mode&quot;:&quot;grid&quot;}}}"></visualization><p>The approval also follows the regulatory run-up that made a USDC clearing house legal: last December the CFTC's digital-asset pilot let futures merchants <a href="https://proofoftalk.io/blog/crypto-derivatives-clearing-ccps/">take bitcoin, ether and USDC as customer margin</a>, reversing an advisory that had kept virtual currency off that list. Coinbase is building the matching infrastructure for a change in what regulators allow clearinghouses to hold.</p> <img data-src="https://imgproxy.citrusreader.com/eXEvsdznYen21b1npjcODB_RyOV0qYW_QeJMMxjbqg0/raw:1/aHR0cHM6Ly9jZG4uYWludmVzdC5jb20vYWlnYy9oeGNtcC9pbWFnZXMvY29tcHJlc3MtcXdlbl9nZW5lcmF0ZWRfMTc5MDY1NzcwMDEyMi5qcGcucG5n" style="max-width:100%;" src="https://imgproxy.citrusreader.com/eXEvsdznYen21b1npjcODB_RyOV0qYW_QeJMMxjbqg0/raw:1/aHR0cHM6Ly9jZG4uYWludmVzdC5jb20vYWlnYy9oeGNtcC9pbWFnZXMvY29tcHJlc3MtcXdlbl9nZW5lcmF0ZWRfMTc5MDY1NzcwMDEyMi5qcGcucG5n" referrerpolicy="no-referrer"><h2>The price of standing in the middle</h2><p>None of this is free for shareholders. A derivatives clearing organization steps into each trade through novation and stands behind the book with a default fund and its own capital; in a default, losses cascade from the defaulter's margin to the guarantee fund to the clearinghouse's own money before surviving members are touched. Coinbase just took that position onto its balance sheet. What keeps the new risk small is precisely the no-leverage constraint - a fully backed book barely threatens a clearinghouse's capital, which is why Coinbase felt safe bringing this half in-house while leaving the leveraged half with third parties.</p> <fundamentals-card dataurl="https://cdn.ainvest.com/news/visual/visual_components/viz_gjorwmyr.json"></fundamentals-card> <p>That division is the line to watch. Coinbase has already filed rule changes to list <a href="https://www.federalregister.gov/documents/2026/09/23/2026-19407/self-regulatory-organizations-coinbase-derivatives-llc-notice-of-filing-and-immediate-effectiveness">perpetual single-stock futures</a>, cash-settled contracts with no expiration, and it has said those will clear outside for now. If margined products or the single-stock <a data-code="PDC" data-position="stock.2" data-marketid="186" data-stockname="Perpetuals" data-type="stock" href="https://www.ainvest.com/news/coinbase-clearinghouse-usdc-factory-fee-play-2609/#*f:PDC:sc*#">perpetuals</a> ever move into Coinbase Clearing, the same machinery stops being low-risk collateral infrastructure and becomes leveraged counterparty risk on Coinbase's own books.</p><p>Context for what the market is paying: Coinbase captures a record 10.3% of crypto trading volume as of its second quarter, with derivatives volume holding near all-time highs, and subscription-and-services revenue - the stablecoin-adjacent line - made up 48% of net revenue. The stock trades around $50 billion, roughly 17 times forward earnings. A clearinghouse approval is not a quarterly-earnings event on its own; its payoff is the slow compounding of stablecoin float and yield.</p><p>So the instinct to read "Coinbase gets its own clearinghouse" as a march toward dominating US crypto derivatives is half right. It is a real moat - a USDC-settled rail that never closes. But it is a moat funded by putting Coinbase's own capital in the middle of the market, and it is deliberately small: only the no-leverage book comes in-house. Whether the leverage ever follows the collateral in is the single variable that decides if this is a low-risk yield engine or a new balance-sheet liability, and Coinbase has left that choice outside its own clearinghouse for now.</p>

2026/9/29
阅读更多

Why the Market Ignores Iran's Sanctions Relief Offers

<h2>Lead</h2><p>Prediction market pricing for a comprehensive US-Iran nuclear agreement remains stubbornly low, hovering near 14% for a deal before January 2027. Despite a flurry of diplomatic activity and public concessions from the Trump administration, traders continue to discount the likelihood of a resolution. This analysis dissects the divergence between headline-breaking diplomatic news and actual market pricing, examining how resolution constraints and liquidity dynamics keep the probability suppressed.</p><marketpolymarketcard eventid="629791"></marketpolymarketcard><h2>Event Definition</h2><p>The contract in question settles on whether specific terms, notably Iran Reconstruction Funding, will be included in a final US-Iran deal negotiated in 2026. The market resolves based on the inclusion of these terms in any formal agreement or publicly acknowledged framework established before the strict deadline of January 1, 2027, at 04:59 UTC. The core disagreement centers on whether the current diplomatic overtures will culminate in a binding settlement or merely result in temporary de-escalation without concrete economic concessions.</p><h2>Latest News &amp; Information Increments</h2><p>The information environment is currently dominated by contradictory diplomatic signals and a resulting low-information regime for pricing. Iranian officials have privately expressed pessimism about reaching a deal before the US midterm elections, believing <a href="https://www.bloomberg.com/news/articles/2026-09-28/iran-officials-pessimistic-about-deal-with-us-before-midterms">high chance of conflict escalating</a> after the November 3 vote. Despite this pessimism, US officials reported that President Trump is willing to provide sanctions relief and release frozen funds as part of a final deal, contingent on Tehran offering <a href="https://economictimes.indiatimes.com/news/international/world-news/trump-offer-iran-sanctions-relief-frozen-funds-for-concrete-nuclear-progress/articleshow/134554313.cms">'concrete progress' on the nuclear issue</a>. However, President Trump subsequently denied these reports on Truth Social, stating he 'offered them NOTHING,' creating <a href="https://www.usnews.com/news/world/articles/2026-09-28/trump-denies-offering-iran-sanctions-relief-for-nuclear-concessions">immediate noise and confusion</a>.</p><p>Amidst this public spat, mediators continue to work behind the scenes. Qatar is expected to hold separate talks with both nations regarding an amended proposal from Tehran, which involves <a href="https://www.criticalthreats.org/analysis/iran-update-september-28-2026">reopening the Strait of Hormuz</a> under a temporary shipping management arrangement. Furthermore, IAEA Director General Rafael Grossi noted that <a href="https://www.bloomberg.com/news/videos/2026-09-23/iaea-s-grossi-iran-nuclear-inspections-can-resume-fast-video">nuclear inspections could resume quickly</a> if political will exists. Traders appear to treat asset unfreezing and sanctions waivers as mere bargaining chips rather than proof that enrichment limits and inspections are near, <a href="https://www.tradingview.com/news/seekingalpha:8b3a77fa3094b:0-markets-shrug-at-trump-s-nuclear-relief-offer-to-iran/">maintaining skepticism despite the diplomatic activity</a>. Consequently, the market is operating in a state of high noise and low clarity, where effective information is difficult to isolate from political posturing.</p> <img data-src="https://imgproxy.citrusreader.com/MmZmirb3OOXt8s06cQbetSVGzedUfmWh3PLLhvKSyLs/raw:1/aHR0cHM6Ly9jZG4uYWludmVzdC5jb20vYWlnYy9oeGNtcC9pbWFnZXMvY29tcHJlc3MtcXdlbl9nZW5lcmF0ZWRfMTc5MDY1NzkyMDExNi5qcGcucG5n" style="max-width:100%;" src="https://imgproxy.citrusreader.com/MmZmirb3OOXt8s06cQbetSVGzedUfmWh3PLLhvKSyLs/raw:1/aHR0cHM6Ly9jZG4uYWludmVzdC5jb20vYWlnYy9oeGNtcC9pbWFnZXMvY29tcHJlc3MtcXdlbl9nZW5lcmF0ZWRfMTc5MDY1NzkyMDExNi5qcGcucG5n" referrerpolicy="no-referrer"><h2>Market Resolution Rules Analysis</h2><p>The market resolves based on the inclusion of specific terms, such as Iran Reconstruction Funding, in a final 2026 US-Iran deal. The determination relies on official announcements or verifiable public records of an agreement. The strict time boundary for resolution is January 1, 2027, at 04:59 UTC. Any agreement reached after this timestamp, or any vague verbal understanding not formally documented, will result in a 'No' settlement. The primary source for verification is expected to be official government statements or recognized treaty documents.</p><h2>Rule Risk Points &amp; Disputed Scenarios</h2><p>The primary risk lies in the ambiguity of what constitutes a 'final deal.' A temporary ceasefire or a verbal understanding between mediators and officials may not meet the strict criteria for inclusion, even if it effectively halts hostilities. Additionally, if the deal includes reconstruction funding implicitly rather than explicitly, or if it is structured as a series of separate executive orders rather than a single treaty, it could trigger a disputed settlement. There is also the risk of a deal being reached but delayed in formal ratification past the January 1 deadline.</p><h2>Market Overview</h2><p>The market pricing reflects a strong consensus against the inclusion of Iran Reconstruction Funding in a 2026 deal. The last trade price of 0.13 and a mid-price of 0.14 suggest that traders perceive <a href="https://cryptobriefing.com/iran-sets-conditions-for-ending-us-hostilities-qatar-mediates/">probability of inclusion as very low</a>, resting firmly in the lower tier of the probability spectrum. This is further reinforced by the 'No' outcome price of 0.86, indicating a significant majority expectation against the affirmative scenario. The market appears decisively settled, with prices far from the 0.5 threshold that typically characterizes high-uncertainty environments. The low volatility score of 0.1625 contrasts with a high activity score of 0.8884, suggesting that while trading interest remains steady, the price itself is not experiencing erratic swings . Recent repricing trends show minimal movement, with both one-day and one-week price changes registering at 0.025, indicating a stable but pessimistic pricing structure .</p><h2>Market Dynamics (Volatility &amp; Volume)</h2><p>Volatility in this market has been relatively contained, with a maximum 1-day price change of 0.025 and a maximum 1-week price change of 0.015 . The 1-month price change of 0.07 suggests that some repricing has occurred over a longer horizon, likely driven by the collapse of the June 2026 ceasefire and the resumption of military actions . The dominance of Market 2663603 in 1-day, 1-week, and 1-month volatility metrics indicates significant price discovery within this specific instrument .</p><p>Volume supports this stability. The market enjoys strong trader engagement, with a total volume of over 1.16 million shares . The 24-hour volume of approximately 65,207 shares falls within the strong range of $50,000 to $150,000, indicating healthy liquidity . The bid-ask spread of 0.02 (between 0.13 and 0.15) is reasonably tight for a niche prediction market, suggesting that current prices are representative of supply and demand dynamics . The absence of significant volume spikes during the recent news fluctuations suggests that traders are not aggressively repositioning based on the daily noise, but are instead holding firm to their low-probability view.</p><h2>Trading Judgment &amp; Follow-up Observation Points</h2><p>The current market pricing is well-supported by the lack of a formal, verifiable agreement and the high degree of diplomatic ambiguity. Traders are correctly discounting the likelihood of a comprehensive deal before the January 1, 2027 deadline. Going forward, the most important variables to track are any formal announcements from the US Treasury or State Department regarding the release of frozen funds, and any IAEA reports confirming the resumption of inspections. Additionally, monitoring the volume and price action around the November 3 US midterm elections will be critical, as Iranian officials have indicated a high chance of conflict escalation post-election, which could further depress the probability of a pre-deadline deal.</p>

2026/9/29
阅读更多

XRP's $5.40 Chart Call Is a Prediction, Not a Trade

<p>Legendary chartist Peter Brandt looked at more than a decade of XRP's price history and saw a pattern he says points to $5.40 - roughly <a href="https://news.bitcoin.com/market-updates/peter-brandt-says-xrp-charts-alone-give-him-reason-to-make-a-bet/">251% above the $1.54</a> where the token traded when he flagged it on September 21. Then he added the line that matters more than the target: posting a chart is not the same thing as taking a trade. For a retail investor deciding whether to own <a data-code="XRPUSDT" data-position="stock.7" data-marketid="UBAX" data-stockname="XRP" data-coinbase="XRP" data-type="crypto" href="https://www.ainvest.com/news/xrp-5-40-chart-call-prediction-trade-2609/#*f:XRPUSDT:sc*#">XRP</a>, that caveat is the most useful sentence in the story, because it separates a pretty picture from the <a data-code="861013" data-position="stock.1" data-marketid="89" data-stockname="Machinery Ⅲ (Industry)" data-type="stock" href="https://www.ainvest.com/news/xrp-5-40-chart-call-prediction-trade-2609/#*f:861013:sc*#">machinery</a> that would have to do the work to get there.</p><p>Brandt made the warning explicit. "<a href="https://finance.yahoo.com/markets/crypto/articles/veteran-trader-peter-brandt-says-143215899.html">A claim of a 'call' or simple presentation of a chart is NOT a trade</a>," he said, and he has never confirmed holding a position. In late 2024, when he was calling attention to the same coiled-up structure he now highlights - his "massive coil" - he stated flatly that he held no XRP and had no plan to buy. His fresh interest in September 2026 is the same kind of note: he finds the long-term pattern worth a bet, he says, but he has pointedly <a href="https://www.cointribune.com/en/xrp-draws-fresh-interest-from-veteran-trader-peter-brandt/?utm_source=snapi">not repeated the $5.40 number or attached a timeline</a>. A chartist's stamp is an opinion about where the tape could go. It is not money placed.</p><p>That is the whole distinction between a prediction and a transmission channel, and it is where the real analysis begins. Brandt's $5.40 is an outcome number, a target printed on a chart. To take it seriously you ask not whether the pattern looks pretty, but whether any observable mechanism exists that could carry XRP to roughly triple its market value - from about $93 billion today to something near $340 billion. A target without a channel sized to reach it is a story.</p><backtest-component code="XRPUSDT" id="strategy_002" range="3" market="UBAX"></backtest-component> <img data-src="https://imgproxy.citrusreader.com/cGP7bf5TWFBymkxSqXvY0bE8ZI90M7v8EdW3Z997gfQ/raw:1/aHR0cHM6Ly9jZG4uYWludmVzdC5jb20vYWlnYy9oeGNtcC9pbWFnZXMvY29tcHJlc3MtcXdlbl9nZW5lcmF0ZWRfMTc5MDY1NzcyNTM0OC5qcGcucG5n" style="max-width:100%;" src="https://imgproxy.citrusreader.com/cGP7bf5TWFBymkxSqXvY0bE8ZI90M7v8EdW3Z997gfQ/raw:1/aHR0cHM6Ly9jZG4uYWludmVzdC5jb20vYWlnYy9oeGNtcC9pbWFnZXMvY29tcHJlc3MtcXdlbl9nZW5lcmF0ZWRfMTc5MDY1NzcyNTM0OC5qcGcucG5n" referrerpolicy="no-referrer"><p>For XRP the clearest, most measurable institutional channel is the spot ETF complex, which arrived in September 2025 and then clustered in November after the SEC's new generic listing standards took hold. Seven U.S. spot funds now run, and they have pulled in roughly <a href="https://finance.yahoo.com/markets/crypto/articles/xrp-etfs-hit-2026-record-132559397.html">$1.66 billion of cumulative net inflows</a> since launch - making XRP <a href="https://ripple.com/insights/xrp-etfs-the-institutional-era-has-begun/">the fastest digital asset to reach $1 billion in ETF inflows since Ethereum's funds</a>. The buyers are genuinely institutional: <a href="https://ripple.com/insights/xrp-etfs-the-institutional-era-has-begun/">Goldman Sachs disclosed a $153.8 million position in XRP ETFs</a> in its Q4 2025 13F filing, the largest known U.S. institutional holder, joined by <a data-code="MGIH" data-position="stock.4" data-marketid="186" data-stockname="Millennium Group" data-type="stock" href="https://www.ainvest.com/news/xrp-5-40-chart-call-prediction-trade-2609/#*f:MGIH:sc*#">Millennium</a> and Citadel. In the week ending August 28, 2026, XRP funds took in <a href="https://finance.yahoo.com/markets/crypto/articles/xrp-etfs-hit-2026-record-132559397.html">$110.49 million, a record for the year</a>, even as <a data-code="BTCUSDT" data-position="stock.9" data-marketid="UBAX" data-stockname="Bitcoin" data-coinbase="BTC" data-type="crypto" href="https://www.ainvest.com/news/xrp-5-40-chart-call-prediction-trade-2609/#*f:BTCUSDT:sc*#">Bitcoin</a> funds saw <a href="https://finance.yahoo.com/markets/crypto/articles/xrp-etfs-hit-2026-record-132559397.html">net outflows of $201.81 million and Ethereum funds $102.18 million</a>. JPMorgan's first-year inflow forecast runs <a href="https://ripple.com/insights/xrp-etfs-the-institutional-era-has-begun/">between $4 and $8.4 billion</a>.</p><visualization data="{&quot;components&quot;:[{&quot;show_type&quot;:&quot;jgyNewLowcode&quot;,&quot;data&quot;:{&quot;columns&quot;:[{&quot;type&quot;:&quot;Object&quot;,&quot;index_name&quot;:&quot;strategy_basic_info&quot;,&quot;key&quot;:&quot;strategy_basic_info&quot;},{&quot;type&quot;:&quot;Object&quot;,&quot;index_name&quot;:&quot;backtest_condition&quot;,&quot;key&quot;:&quot;backtest_condition&quot;},{&quot;type&quot;:&quot;STR&quot;,&quot;index_name&quot;:&quot;backtest_result&quot;,&quot;key&quot;:&quot;backtest_result&quot;}],&quot;datas&quot;:[{&quot;backtest_result&quot;:&quot;https://cdn.ainvest.com/backtest/agent/session/784562/visual-component/ce1bca95-278d-419e-94e0-8ee4573ffee5/xrp_backtest_results.json&quot;,&quot;backtest_condition&quot;:{&quot;risk_control&quot;:{&quot;display_name&quot;:&quot;Risk Control&quot;,&quot;parameters&quot;:{&quot;take_profit&quot;:{&quot;unit&quot;:&quot;%&quot;,&quot;display_name&quot;:&quot;Take-Profit&quot;,&quot;value&quot;:8},&quot;stop_loss&quot;:{&quot;unit&quot;:&quot;%&quot;,&quot;display_name&quot;:&quot;Stop-Loss&quot;,&quot;value&quot;:4},&quot;max_holding_days&quot;:{&quot;display_name&quot;:&quot;Hold Days&quot;,&quot;value&quot;:20}}},&quot;open_signal&quot;:{&quot;criteria&quot;:&quot;Price breaks above the 20-day Donchian high&quot;,&quot;display_name&quot;:&quot;Open Signal&quot;,&quot;type&quot;:&quot;criteria&quot;},&quot;sell_signal&quot;:{&quot;criteria&quot;:&quot;Price closes below the 200-day SMA, or after 20 trading days, or TP +8%, SL -4%&quot;,&quot;display_name&quot;:&quot;Close Signal&quot;,&quot;type&quot;:&quot;criteria&quot;},&quot;object&quot;:{&quot;ticker&quot;:[&quot;XRP&quot;],&quot;display_name&quot;:&quot;XRP&quot;,&quot;type&quot;:&quot;ticker&quot;}},&quot;strategy_basic_info&quot;:{&quot;name&quot;:&quot;XRP Long-Only Donchian Breakout Strategy&quot;,&quot;description&quot;:&quot;A long-only strategy for XRP that enters when price breaks above the 20-day Donchian high and exits when price closes below the 200-day SMA, after 20 trading days, or at TP/SL levels.&quot;}}]},&quot;config&quot;:{&quot;type&quot;:&quot;iwcapp/stockBackTestTool&quot;,&quot;version&quot;:&quot;0.0.3&quot;,&quot;url&quot;:&quot;//cdn.ainvest.com/frontResources/s/foiegras/stockBackTestTool/0.0.3/stockBackTestTool@0.0.3index.js&quot;},&quot;uuid&quot;:&quot;1789720675284_c98d71a1&quot;}],&quot;page&quot;:{&quot;layout&quot;:{&quot;layout_data&quot;:&quot;[{\&quot;uuid\&quot;: \&quot;1789720675284_c98d71a1\&quot;, \&quot;show_type\&quot;: \&quot;jgyNewLowcode\&quot;}]&quot;,&quot;layout_mode&quot;:&quot;grid&quot;}}}"></visualization><p>Now size that channel against the task. The ETF complex holds only on the order of 1% of XRP's roughly 100 billion total token supply - a real footprint, but a small one when the bull case is a 251% move. And that institutional bid has so far failed to levitate the price. XRP trades near $1.49 today, roughly half its $3.04 52-week high and about 22% lower over the past year, and it still sits below its 18-month moving average near $1.88. Institutions have been buying at the desks while the market value has gone sideways to down. That divergence is worth studying, not cheering.</p><p>What would turn Brandt's pattern into more than a headline? On his own short-term read, a decisive breakout above <a href="https://www.cointribune.com/en/xrp-draws-fresh-interest-from-veteran-trader-peter-brandt/?utm_source=snapi">the $1.55–$1.66 resistance zone</a> opens the path toward $2, while losing $1.45 weakens the setup. But the mechanical tells that matter more for a holder are whether ETF inflows keep growing as a share of supply, whether the settlement utility the token is sold on - Ripple's <a data-code="RLUSDUSDT" data-position="stock.11" data-marketid="UBAX" data-stockname="RLUSD" data-coinbase="RLUSD" data-type="crypto" href="https://www.ainvest.com/news/xrp-5-40-chart-call-prediction-trade-2609/#*f:RLUSDUSDT:sc*#">RLUSD</a> <a data-code="SDEV" data-position="stock.6" data-marketid="170" data-stockname="Stablecoin" data-type="stock" href="https://www.ainvest.com/news/xrp-5-40-chart-call-prediction-trade-2609/#*f:SDEV:sc*#">stablecoin</a> and XRPL transaction volume - starts showing up in price rather than in press releases, and whether XRP can reclaim and hold above that 18-month average. If the institutional channel keeps expanding into weakness and the token clears its old highs, the $5.40 path becomes a transmission story. If inflows stall again, as they did through most of 2026, and price keeps sliding below its trend line, then Brandt's beautiful chart remains exactly what he calls it: a chart, not a trade.</p><p>The professional habit worth copying is Brandt's own. He keeps the pattern analysis and the balance-sheet reality in separate boxes, and he is explicit that a printed prediction implies no position and no loss. Follow his discipline rather than his stamp: treat $5.40 as a chartist's opinion, then go find the channel that would have to carry the price there, and watch that channel. That is how a beginner gets the benefit of a sharp trader's eye without inheriting his risk.</p>

2026/9/29
阅读更多

推荐订阅

TokenInsight - Research

Language: | Chinese | English | | ------- | ------- | | zh | en |

TokenInsight - Blogs

TokenInsight - Latest

TheBlock - Category

Get latest news from TheBlock by category. Note that due to website limitations, only article summaries may be available.

S&P Global - Ratings

| language | Description | | -------- | ----------- | | zh | 中文 | | en | English | | es | Español | | pt | Português | | jp | 日本語 | | ru | Русский | | ar | العربية |